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ABSTRACT
Our genetic inheritance begins with one genome copy from each parent. The presence of one or
more errors in either the maternal or the paternal genome can lead to genetic disease or disruption of the
embryonic program and potential loss of the offspring. Numerous chemical and physical toxicants are
known to produce germ line mutagenesis based on their ability to produce DNA sequence mutations.
Exposures to these cytotoxic and mutagenic agents pose a risk for human offspring. However, very little
is known regarding the sensitivity of the epigenetic patterns involved in reproductive functions to
adverse effects of chemical agents. The present study was undertaken to address the potential for
ethylene dichloride (EDC) to disrupt the epigenetic programming of the paternal genome in mammalian
(mouse) sperm.
Unfortunately, it is very difficult to study developing germ cells such as spermatogonia and their
precursor spermatogonial stem cells within the in vivo mouse testis model. Thus, an in vitro mouse
spermatogonial stem cell model was developed that enabled the triggering of a spermatogenesis
differentiation pathway in these stem cell cultures. Since the epigenetic imprint patterns are reported to
be established in the spermatogonial stem cell of prior to meiosis, this in vitro model enabled the
treatment and study of the effects of EDC on DNA, 5-methlcytosine and histone modifications in the
paternal gamete. Paternally imprinted genes, such as H19, Gtl2, and Rasgrf1, showed changes in
histone methylation modifications in ethylene dichloride treated spermatogonia. These data demonstrate
that ethylene dichloride can disrupt the genomic imprint in developing sperm, and thus perturb the
embryonic programming of potential offspring in the mouse model. This work suggests that EDC may
have the potential to cause genetic diseases in offspring from exposed males.

vii

CHAPTER 1
ETHYLENE DICHLORIDE AND GENETIC IMPRINTING
Disruption of male reproductive function due to exposure to cytotoxic agents (such as
environmental toxicants) and cancer therapies (such as chemotherapy and ionizing radiation) has been
well documented (Gandini, Sgro et al. 2006). Alkylating agents are known to disrupt the male
reproductive function by interfering with or damaging the endocrine system (Greim 2005), and Sertoli
and Ledig cells (Forbes 1978; Kopf-Maier 1992), as well as the spermatogonial stem cells (Maguire,
Dick et al. 1981).
Damage to spermatogonial stem cells is the most important since these are the cells that
differentiate into gametes that harbor the genetic information for the next generation of. Two distinct
pathways, genetic and epigenetic, transmit inherited genetic information. According to classic
evolutionary theory, phenotypic variation is due to heritable genetic mutations. It is now known that
other heritable mechanisms can contribute to phenotypic variation. It is these mechanisms, known as
epigenetics, that give organisms a plasticity of heritable phenotypes (Rando and Verstrepen 2007).
Epigenetics is defined as the study of mitotically and or meiotically heritable changes in gene function
that cannot be explained by changes in DNA sequence (Russo et al. 1996).
Establishment and reprogramming of epigenetics is a process by which the expression of an
organism‟s genotype may be altered to produce phenotypic variations, despite an absence of change in
the genetic information (Tang and Ho 2007). Heritable epigenetic information is transmitted to the next
generation by three main and interlinked systems: DNA 5-methycytosine patterns (Baylin 1997; Jones
and Takai 2001), histone tail modifications (Lacoste and Cote 2003; Margueron, Trojer et al. 2005), and
small-interfering RNAs (Morris 2005). Alterations in these modifications have been implicated in basic
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cellular processes such as embryogenesis, differentiation, carcinogenesis, and even aging (Wilson,
Smith et al. 1987).
1.1 Ethylene Dichloride (EDC)
Ethylene dichloride (EDC), also known as 1,2-dichloroethylene, is a highly flammable,
colorless liquid with a sharp, harsh odor that can be detected by smell at approximately 17 ppm in air
(ATSDR 2001). EDC is a high-use chemical in today's industry for the synthesis of vinyl chloride, as a
chlorinated solvent, and as a constituent in paints, soaps, scouring compounds, and metal degreasers
(ATSDR 2001). EDC has also been used as an extracting solvent for spices and other natural flavorings,
including tobacco. The production of EDC in the United States was about 16 million metric tons in
1994 (ATSDR 2001). In Louisiana, the total EDC discharge for 1987 to 1993 was greater than 5598
metric tons (LDEQ 1995).
EDC is a known mutagen requiring metabolic activation by glutathione conjugation (Inskeep,
Koga et al. 1986; Cmarik, Humphreys et al. 1992). Glutathione-dependant metabolites, such as S- (2chloroethyl) glutathione and S- (2-chloroethyl)-L-cysteine, spontaneously rearrange to form reactive
episulfonium ions that react with nucleophilic sites on cellular macromolecules, including DNA
(Peterson, Harris et al. 1988; Romert, Magnusson et al. 1990). The major DNA adduct formed from
EDC is reported to be N7-ethyl-S-glutathionyl deoxyguanosine (Romert, Magnusson et al. 1990;
Cmarik, Humphreys et al. 1992). Interestingly, the mutation spectrum produced by EDC and other
dihaloethanes appears to be limited to G  A transitions (Aafjes, van der Vijver et al. 1978; Cmarik,
Humphreys et al. 1992). Since most tissues contain glutathione and glutathione-S-transferase, EDC can
react and damage multiple organ systems, including testis. The US EPA has designated EDC as a
potential carcinogen, hazardous substance, and priority toxic pollutant (EPA 2000). EDC is also
designated as a possible human carcinogen, (Group 2B) by the International Agency for Cancer
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Research (IARC 2006). Early studies with EDC have reported little or no reproductive toxicity.
Inhalation studies showed only embryo toxicity at high doses and no significant reproductive toxicity
(Lane, Riddle et al. 1982); (Hurtt, Valentine et al. 1993). Rats and mice exposed to this highly volatile
compound in drinking water or in diet showed no effects on fertility (Alumot, Meidler et al. 1976) and
lacked remarkable pathology in reproductive tissues (Daniel, Robinson et al. 1994).
These reports of limited reproductive and testicular toxicity by EDC are surprising, since tissues
with significant mitotic indexes are generally sensitive to reactive compounds, such as the activated
EDC-glutathione episulfonium ion. Mammalian gonadal tissues are well known to be sensitive to
cytotoxic agents. The loss of fertility in males due to therapeutic ionizing radiation and chemotherapy
has been well documented (Chapman 1983; Meistrich 1984; Meistrich and Samuels 1985; Meistrich
1993).

Previous studies demonstrated that the closely related chemical, 2-chloroethyl

methanesulfonate, is a potent premeiotic mutagen capable of inducing mutant offspring and sterility in
Drosophila (Fossett, Byrne et al. 1994). In addition to induced DNA sequence mutations, EDC may
also cause mutant offspring by perturbing the epigenetic imprint in the gametes.
1.2 DNA Methylation
Genomic imprinting is a genetic phenomenon by which certain genes are expressed in a parent
of origin specific manner (Delaval and Feil 2004; Morison, Ramsay et al. 2005). Once referred to as the
“parent of origin effect” (Crouse 1960), forms of genomic imprinting have been demonstrated in
insects, mammals, and flowering plants (Sapienza 1990); (Moore and Haig 1991; (Scott, Spielman et
al. 1998). Current models explain mammalian genetic imprinting (in particular for genes involved in
placenta and fetal growth) by indicating that growth enhancers are expected to be imprinted and thus are
transcriptionally silent on maternal alleles, just as growth suppressors are expected to be imprinted and
thus are also transcriptionally silent on paternal alleles. This theory is known as the Kinship Theory of
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Imprinting, and implies an evolutionary conflict between maternal and paternal alleles within an
organism (Haig 2004).
In the early 1980s, researchers found that maternal and paternal chromosomes functioned
differently in developing embryos (Barton, Surani et al. 1984; McGrath and Solter 1984). By 1990,
DNA cytosine methylation patterns for a subset of genes were discovered to be different on the
maternal versus paternal genome (Feil, Walter et al. 1994; Eden and Cedar 1995). The term imprinting
became identified with the fact that maternal and paternal subsets could be identified in an embryo by
these distinct DNA cytosine methylation patterns.
Imprinted genes are thought to play a key role in embryonic and placental development, as well
as some postnatal development (Moore and Haig 1991; Tycko and Morison 2002; Constancia, Kelsey et
al. 2004). Several inherited diseases are due to either genetic imprinting defects such as Prader-Willi
and Angelman Syndrome, which occur either from a deletion of the imprinting region of one of the
parental alleles, or due to uniparental disomy (UPD).
UPD is the presence in a diploid individual of a chromosome pair, derived from only one parent.
Unfortunately, UPD results in the inheritance of only one parental imprint on all imprinted genes
residing on the chromosome pair, coupled with the lack of a balanced developmental program. UPD
may play a role in both the phenotypic expression of recessive autosomal diseases and imprinting
errors. In 1991, the first reported clinical case of UPD involved a girl with cystic fibrosis and unusually
short stature who carried two copies of maternal chromosome 7. Since 1991, 29 of 47 possible cases of
UPDs have been identified among individuals ascertained for medical reasons (Cotter, Kaffe et al.
1997; Sutton and Shaffer 2000; Sutton, McAlister et al. 2003).
The first imprinted gene discovered in male germ cells was H19/Igf2 (Davis, Yang et al. 2000;
Li, Lees-Murdock et al. 2004). Of all the known imprinted genes only three are known to be
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methylated in the male germ cells; H19/Igf2, Rasgrf1/A19, and Dlk1/Gtl2 (Shibata, Yoda et al. 1998;
Takada, Paulsen et al. 2002). Sequence regions that are important in the regulation of these imprinted
genes are differentially methylated regions (DMR) that closely reside near imprinted genes (Li,Beard et
al. 1993; Schmidt, Matteson et al. 2000). In male germ cells, de novo methylation of the DMRs occurs
during the early stages of spermatogenesis. However, these DMRs are not fully methylated until the
mature sperm stage (Li, Lees-Murdock et al. 2004). Exactly when paternal genetic imprinting patterns
are established in gametogenesis is still a matter of debate and the literature is confusing regarding the
course of epigenetic events (Shamanski, Kimura et al. 1999; Miki, Lee et al. 2004).
It appears that in mammalian development, there are two demethylation/remethylation events.
The first occurs rapidly after fertilization. In mice, the paternal pronucleus undergoes dramatic
demethylation, immediately after fertilization and prior to the first cleavage (Mayer, Niveleau et al.
2000). However, imprinted genes are protected from this initial reprogramming and maintain the
parental-specific DNA 5-methycytosine patterns (Reik and Walter 2001). The second wave of
demethylation/remethylation occurs during oogenesis and spermatogenesis for reprogramming and
establishing the gender-specific imprint for the next generation. In spermatogenesis, the paternal
imprint is established in spermatogonial stem cells, or in the early stages of differentiation commitment
pre-meiotic spermatogonia (Holmes and Soloway 2006).
During spermatogenesis, paternal imprinting de novo methylation is associated with the
silencing of CCCTC-binding factor zinc finger protein (CTCF) and activation of Brother of the
Regulator of Imprinted Sites (BORIS) (Klenova, Morse et al. 2002). BORIS seems to be involved with
early erasure of methylation along with a currently unknown demethylase(s) (Loukinov, Pugacheva et
al. 2002). Expression of BORIS, as well as Dnmt3L and Dnmt3a de novo methyltransferases, were
detected between the spermatogonia and spermatocyte stages just prior to meiosis (Rousseaux, Caron

5

et al. 2005). By the post meiotic spermatocyte stage, paternal imprints were established, suggesting that
spermatogonial meiotic differentiation commitment may trigger paternal imprint establishment. Clearly,
this indicates that paternal imprints are established prior to meiosis (Rousseaux, Caron et al. 2005).
One characteristic of imprinted genes is that about 80% are physically linked in clusters (Reik
and Walter 2001). Clusters may contain as many as 15 genes, as in the case of chromosome 7, which
contains Ins2, Igf2, and H19, among others (Engemann, Strodicke et al. 2000; Paulsen, El-Maarri et al.
2000). This sort of arrangement suggests common regulation and establishment. Imprinted gene clusters
are regulated by the neighboring DMRs. Imprinted genes are bi-allelically expressed in germ cells from
the time that primordial germ cells (PGCs) colonize the fetal gonad until the spermatogonial stem cell
stage, or possibly as late as the early stages of pre-meiotic spermatogonia in the male (Szabo and Mann
1995). This suggests that imprints are erased during germ cell development, at least for the PGCs
(Shamanski, Kimura et al. 1999).
At least some imprinted genes have the correct parental establishment, even in immature mice
(Miki, Lee et al. 2004). H19 /Igf2, Meg3, and Igf2r showed proper parental expression in prepubescent
mice when round spermatids were used to micro-inseminate female mice. In a review by Rousseaux et
al., paternal imprints were thought to be established by the spermatocyte stage, before the round
spermatid stage (Rousseaux, Caron et al. 2005). Of the identified DMRs, only three are known to be
methylated in the paternal germ line (Delaval and Feil 2004). These are also known as imprinting
control regions (ICRs). Unlike maternal methylated DMRs, paternal methylated DMRs are not located
in promoter regions or within a gene (Kobayashi, Suda et al. 2006). The DMR for H19 is upstream of
the H19-Igf2 locus on the distal side of chromosome 7 (Thorvaldsen, Duran et al. 1998). The DMR for
Gtl2 is upstream of the Dlk1-Gtl2 domain located on chromosome 12 (Lin, Youngson et al. 2003). The
DMR for Rasgrf1 is located upstream on chromosome 9 (Yoon, Herman et al. 2002). In all three of
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these DMRs de novo methylation starts before birth in PGCs at 14.5-18.5 days postcoitum, while only
the H19 is fully methylated in pachytene spermatocytes (Davis, Yang et al. 2000; Li, Lees-Murdock et
al. 2004; Delaval, Govin et al. 2007).
This study focused on these DMRs rather than gene promoters, because disruption in DMRs is
known to affect imprinting (Rayburn, Parker et al. 2004). However, DNA cytosine methylation patterns
may represent only part of the imprinting control mechanism. Genetic imprinting may also be linked or
controlled by histone modifications.
1.3 Histone Modifications and Imprinting
In eukaryotic cells, the basic repeating unit of chromatin structure is the nucleosome containing
two copies of four core histone proteins H2A, H2B, H3, and H4, wrapped by ~ 147 bp of DNA (Luger,
Mader et al. 1997). Modifications to histone N-terminus tails were first reported in 1964 (Allfrey,
Faulkner et al. 1964). Histone subunit modifications consist of methylation (McKittrick 2004; Kondo
2004), phosphorylation (Toh, O'Shaughnessy et al. 2006), acetylation (Yamada, Mizuno et al. 2004),
ubiquitinylation (Shahbazian, Zhang et al. 2005), and sumoylation (Iniguez-Lluhi 2006), commonly
referred to as the histone code (Biel, Wascholowski et al. 2005). This histone code is thought to either
direct and or mark the DNA (Kondo, Shen et al. 2004) for cytosine methylation and for chromosomal
remodeling (Henikoff 2005; Hidenobu and Wagstaff 2005). In Drosophila and the mouse, lysine in the
ninth position on the N-terminus tail of histone 3 (H3K9) methylation was linked with DNA
methylation and heterochromatin, while H3K4 methylation was linked with euchromatin and active
genes (McKittrick 2004; Kondo 2004). Also, histone methylation can be mono (Talasz, Lindner et al.
2005), di (Khalil and Driscoll 2006) or tri (Schneider, Wood et al. 2005) on lysine residues, which
amplifies the diversity of control mechanisms intrinsic to the histone code.
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A list of histone modifications and their association with gene expression is displayed in Table 1.1.
Enzymes identified in the formation and removal of histone modifications are listed in Table 1.2.

Table 1.1 Histone Modifications and Gene Expression
Histone
Modification
Methylation

Acetylation

Phosphorylation

Ubiquitination

Biotinylation
Proline
isomerization

Histone
H3K4
H3K9

Functional Effect on
Gene Expression
On
Off

H3K27
H3K36
H1K26
H3K79
H4K20
H4R3
H2BK11
H3K9
H3K14
H3K56
H4K5
H4K12
H4K16
H2BS14 (human) &
H2BS10 (yeast)
H3S10
H3S28
H4S1
H2AK119ub1
H2BK120ub1(human),
H2BK123ub1(yeast)
H2BK123ub1
biotinylated H4K12

Off
Off (?)1
Off (?)2
Off
Off
Off 3
Off (?)3
On
On
Off (?)1
On
Off
On
Unknown (?)1

H3P38

Unknown (?)1

On
On (?)
Unknown (?)1
On (?)1
Unknown (?)1
On
Off

1

see Bhaumik, Smith et al. 2007;
see Jenuwein & Allis, 2001
3
see Latham & Dent, 2007
2
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Table 1.2 Enzymes Involved In Histone Modifications 1
Enzymes 2

Covalent modifications
H3K4 methylation
H3K9 methylation
H3K27 methylation
H3K36 methylation
H3K79 methylation
H4K20 methylation
H3R2 methylation
H3R26 methylation
H4R3 methylation
H3K9 acetylation
H3K14 acetylation
H3K18 acetylation
H3K23 acetylation
H3K36 acetylation
H3K56 acetylation
H4K5 acetylation
H4K8 acetylation
H4K12 acetylation
H4K16 acetylation
De-acetylation3
H3S10 phosphorylation
H3S28 phosphorylation
H4S1 phosphorylation
H2BS phosphorylation (S14
in human; S10 in yeast)
H2BK11 acetylation
H2AS129 or H2AXS139
phosphorylation

Set1 (Sc), SET7/SET9 (Hs), MLL (Hs), Smyd3 (Hs), Prdm9
SUV39H1 & SUV39H2 (Mm, Hs), G9a (Mm, Hs), Eu-HMTase1
(Hs), ESET & SETDB1 (Mm, Hs), Clr4 (Sp), Dim5 (Nc),
Kryptonite (At), Ash1 (Dm)
E(z) (Dm), EZH2 (Hs, Mm)
SETD2/HYPB (Hs), NSD1 (Hs), Set2 (Sc)
DOT1 (Sc), DOT1L (Hs)
Pr-SET7/SET8 (Hs, Dm), SUV4-20 (Hs), SET9 (Sp)
CARM1 (Mm, Hs)
CARM1 (Mm, Hs)
PRMT1 (Hs), RMT1 (Sc)
Gcn5 (Sc), Src1 (Mm)
Gcn5 (Tt, Sc), Src1 (Mm), TAF1 (Dm, Hs), CBP & p300 (Hs),
Sas3 (Sc), MOZ & MORF (Hs), PCAF & hGcn5 (Hs)
Gcn5 (Sc), CBP & p300 (Hs)
Gcn5 (Sc), CBP (Hs), Sas3 (Sc)
Gcn5 (Sc)
Rtt109 (Sc)
Esa1 (Sc), Hat1 (Tt, Dm, Hs), p300 (Hs), Tip60 (Mm), HBO1 (Hs)
p300 (Hs), Esa1 (Sc), Tip60 (Mm), p300 (Hs), HBO1 (Hs)
Hat1 (Sc), Esa1 (Sc), Tip60 (Mm) and CBP & p300 (Hs), HBO1
(Hs)
Mof (Dm), hMof (Hs), Sas2 (Sc), Tip60 (Mm), Esa1 (Sc)
HDAC‟s (class I)
Hos3 (class II) and the sirtuins (class III)

Snf1 (Sc), Jil-1 (Dm), Rsk2 (Mm, Hs), Msk1 (Mm), lp11(Sc),
Aurora B (Ce, Dm, Hs), NIMA (An)
Aurora B (Mm, Hs)
Sps1 (Sc), CKII (Sc)
Mst1 (Hs), Ste20 (Sc)
Gcn5 (Sc)
Tel1 & Mec1 (Sc), ATM & ATR & DNAPK (Hs)
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Enzymes 2

Covalent modifications
H2AK5 acetylation
H2AK119 ubiquitination
H2BK ubiquitination (K120 in
human, K123 in yeast)
H2AZK14 acetylation

Tip60 (Hs, Dm)
Ring1B (Dm, Mm, Hs)
Rad6 (Sc), Bre1 (Sc), HR6A (Hs), HR6B (Hs)
Esa1 (Sc), Gcn5 (Sc)

1

Adapted from (Bhaumik, Smith et al. 2007)
An, Aspergillus nidulans; Ce, Caenorhabditis elegans; Dm, Drsophila melanogastger;
Hs, Homo sapiens; Mn, Mus musculus; Sc, Saccharomyces cerevisiae;
Sp, Schizosaccharomyces pombe; Tt Tetrahymena thermmophila
3
Gallinari, Di Marco1 et.al. 2007
2

In order to better understand the involvement of the histone code in imprinting and other
epigenetic processes, clarification of the importance and function(s) of the individual histone
modifications is needed:
1.3.1 Histone Acetylation. Histone acetylation is the most studied and best understood histone
modification (Allfrey, Faulkner et al. 1964). Acetylation takes place on the Ɛ amino group on lysine
residues (Turner 1999). Acetylation patterns are established by highly regulated acetylation enzymes,
histone acetyltransferase (HAT‟s) and histone de-acetylates (HDAC‟s) (Kurdistani and Grunstein
2003). HAT enzymes are grouped into different family classes, GNAT family, MYST family and
CBP/p300 family (Roth, Denu et al. 2001). Some transcription factors such as yeast protein Gcn5, a
putative transcriptional adaptor, are HAT enzymes (Brownell, Zhou et al. 1996). Histone acetylation
modifications take place on H3 at K9, K14, and K56; on H4 at K5, K8, K12, and K16; on H2A at K5
and K9; on H2B at K5, K11, K12, K15, and K20 (Biel, Wascholowski et al. 2005) (Table 1.1).
HDACs catalyze the removal of acetyl groups from histones by activation of a water molecule
through a zinc ion in the active site (Finnin, Donigian et al. 1999; Gray and Ekstrom 2001). HDACs are
involved in formation of heterochromatin. In human, 18 non-redundant HDAC‟s have been identified
(Dokmanovic, Clarke et al. 2007). HDAC‟s are divided into three classes, I, II and III (Verdin,
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Dequiedt et al. 2003). Class I HDAC‟s are localized within the nucleus while Class II shuttle between
the nucleus and cytoplasm (Dokmanovic, Clarke et al. 2007). Regulation of HDAC‟s consist of
protein-protein interactions, post-translational modifications, cellular localization, and metabolic
cofactors (Sengupta and Seto 2004). Inhibition of HDAC activity has been found useful in the clinical
treatment of human disease processes. So far 12 different HDAC inhibitors are undergoing clinical
trials (Rasheed, Johnstone et al. 2007).
1.3.2 Histone Methylation. As noted above, specific lysine residues may be mono-, di- or trimethylated (Paik and Kim 1971; Peters, Kubicek et al. 2003). In total, five H3-lysines can be
methylated; K4, K9, K27, K36 and K79 (Lachner, O'Sullivan et al. 2003) (Table 1.1). The transition
from di- to tri- methylation of H3K4 and H3K9 lysines is of particular biological significance. In
general, H3K4me3 methylation is linked to transcriptionally active chromatin or euchromatin (Lachner
and Jenuwein 2002), while H3K9m3 methylation is linked to repressed transcription or heterochromatin
(Lachner and Jenuwein 2002). However, recently H3K9 methylation has also been discovered in
euchromatin (Vakoc, Mandat et al. 2005; Vakoc, Sachdeva et al. 2006) making the meaning and
interpretation of the histone modification a difficult task. Part of this complexity may be due to different
effects of mono-, di-, and tri- methylation, which were not routinely reported in journal articles. Some
data shows that DNA cytosine methylation has a regulatory effect on H3 and H4 deacetylation, as well
as demethylation of H3K4 and methylation of H3K9 sites (Soppe, Jasencakova et al. 2002;
Hashimshony, Zhang et al. 2003).
Histone H3K9 and H3K27 were shown to work in conjunction with the formation of pericentric
heterochromatin, X inactivation, polycomb-mediated gene silencing, and transcriptional repression at
euchromatic positions (Lachner and Jenuwein 2002; Fischle, Wang et al. 2003). Methylation of H3K9
is generally associated with silencing of genes and is closely tied to DNA cytosine methylation and
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genetic imprinting, as well as X inactivation in mammals (Peters, A.H. 2002, Heard, E. 2001).
Reciprocally, H3K4 di- and tri-methylation are associated with active chromatin (Delaval, Govin et al.
2007). Histone arginine methylation, e.g., H4R3, is generally linked to gene activation, while lysine
methylation (H3K4 and H3K9) is linked to both activation and repression (Kouzarides 2002; Fischle,
Wang et al. 2003). Evidence shows that HP1 proteins are associated with DNA methyltransferase
activity, as well as forming a link between histone and DNA cytosine methylation (Bachman, Rountree
et al. 2001; Tamaru and Selker 2001) (Table 1.2). .
Histone methyltransferases Suv39h1 and Suv39h2, methylate H3K4 in mice (O'Carroll,
Scherthan et al. 2000; Peters, O'Carroll et al. 2001) (Table 1.2). Although, Suv39h1 is expressed in
many tissues, Suv39h2 is expressed only in the testis (Peters, O'Carroll et al. 2001). Histone
methyltransferase, Prdm9, is expressed in early meiotic germ cells and is responsible for H3K4me3
formation (Hayashi, Yoshida et al. 2005) (Table 1.2). H3K4 tri-methylation is found in active
chromatin. Since Meisetz methylates only di-methylated H3K4, and cannot methylate mono- or unmethylated lysine‟s, H3K4 must be di-methylated before meiosis (Dawe, Sedat et al. 1994).
Although researchers assumed that histone demethylase existed, nearly 50 years passed before
these enzymes were discovered. Recent research has identified two histone demethylation enzymes
which can remove methyl groups from lysine and arginine residues, lysine specific demethylase 1
(LSD1) and Jumonji C (JmjC) (Cuthbert, Daujat et al. 2004; Wang, Wysocka et al. 2004). LSD1 is able
to demethylate H3K4 m1/2, but not H3K4m3. Since LSD1 requires a protonated nitrogen, tri-methylated
histone lysine is not a suitable substrate.

JmjC domain containing enzymes

all function as

hydroxylation enzymes (Tsukada, Fang et al. 2006). Histone demethylases are now being considered for
anti-cancer therapies (Tian and Fang 2007). LSD1 is closely related to monoamine oxidases (MAO), as
the MAO inhibitor, Pargyline, also inhibits LSD1 (Yang, Gocke et al. 2006).

12

1.3.3 Histone Phosphorylation. Gutierrez and Hnilica in 1967 (Gutierrez and Hnilica 1967)
reported that phosphorylation of H3S10 and H3S28 are found in cell cycle chromatin condensation,
active transcription, apoptosis and DNA repair (Wei, Mizzen et al. 1998; Hirota, Lipp et al. 2005).
Histone H3T11 and H3S28 have been identified as mitosis-specific sites for phosphorylation (Goto,
Tomono et al. 1999; Preuss, Landsberg et al. 2003).
Histone phosphorylation is also involved with activation of early response genes such as c-fos,
c-myc and c-jun. This is a stimulant-dependent H3 phosphorylation, resulting in quick transcriptional
activation by activating activation of a subset of immediate-early (IE) genes (Barratt, Hazzalin et al.
1994). Acetylation and phosphorylation are both linked to transcription activation; however, it is
unknown whether the two modifications work independently, in parallel, or synergistically (Cheung,
Tanner et al. 2000; Clayton, Rose et al. 2000).

The involvement of histone phosphorylation in

imprinting of genes is presently unknown, although the association with active transcription may
suggest a potential role.
DNA cytosine methylation and histone modifications form a complex system of chromatin
modification that regulates gene expression (O'Carroll, Erhardt et al. 2001; Vu, Li et al. 2004; Biel,
Wascholowski et al. 2005; Morgan, Santos et al. 2005). Histone H3K9m3 is linked to DNA methylation,
genetic imprinting and gene repression, while H3K9 acetylation is linked to gene expression and hypomethylated promoters and DMRs (Bernstein, Kamal et al. 2005). Trimethylated marks, H3K9m3 and
H3K27m3, are properties of stably silenced heterochromatin (McGarvey, Fahrner et al. 2006), whereas
H3K9m2 is important for euchromatic gene repression (McGarvey, Fahrner et al. 2006). In mammals,
H3K9 methylation may also direct 5-methyl-cytosine formation in pericentomeric heterochromatin
(Lehnertz, Ueda et al. 2003). McGarvey et al. (2006) showed that when a hypermethylated gene is
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demethylated and re-expressed following 5-azacytidine treatment, H3K9m1 and H3K9m2 are the only
silencing marks on histones that are lost.
It is becoming a general view that histones are major carriers of epigenetic information. As a
result, either synergistically or antagonistically, histones provide mechanisms to generate and stabilize
genetic imprints. Complexes consisting of HDACs, histone methyltransferases, and 5-methylcytosine
binding proteins recruit DNA cytosine methyltransferases (Fuks, Hurd et al. 2003). Finally, H3K4me3, as
a strong and stable activator of transcription was hypothesized to serve as a memory mark to enforce
transcription despite subsequent histone modifications (Ng, Robert et al. 2003; Martin and Zhang 2005;
Yu, Zhu et al. 2008).
Histone tail modifications are also closely linked to one another. Changes in one part of the
histone code facilitate changes in other parts. For example, phosphorylation of H3S10 is reduced when
H3K9 is di-methylated, while H3K9 acetlyation increases H3S10 phosphorylation (Rea, Eisenhaber et
al. 2000; Sims, Millhouse et al. 2007). Also, H3S10 phosphorylation activates HAT activity and
acetylation of H3K14 (Lo, Trievel et al. 2000). Histone modifications and DNA 5-methylcytosine
patterns function with a well regulated system of transcription factors, binding proteins, and other
factors (Goeman, Otto et al. 2008). H3K4m3, localized in the 5‟ region of genes, is associated with
several binding proteins, such as CHD1, BPTF, JMHD2A and the tumor suppressor family, ING.
CHD1, in conjunction with H3K4m3, is involved with pre-mRNA splicing (Sims, Millhouse et al. 2007).
The ING family of tumor suppressor binding proteins acts as chromatin-regulatory proteins and is key
components of HAT/HDAC complexes (Doyon, Cayrou et al. 2006). ING1 and ING2 form an HDAC
co-repressor complex, while ING3, ING4 and ING5 associate with HAT complexes (Goeman,
Thormeyer et al. 2005).
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Maternal chromatin in the mouse zygote maintains globally methylated H3K9 and DNA
cytosine methylation, but the paternal chromatin lacks H3K9 global methylation and DNA cytosine
methylation (Arney, Bao et al. 2002; Lepikhov and Walter 2004; Liu, Kim et al. 2004; Yeo, Lee et al.
2005), which would suggest a dependent linkage. The theory is that H3K9m3 in the maternal pronucleus
protects the maternal DNA from demethylation, while a lack of H3K9m3 in the paternal pronucleus
allows global DNA hypomethylation to occur (Santos, Peters et al. 2005). There are high levels of
H3K9me3, in the mouse arrested maternal oocyte chromosome prior to fertilization. In this case, the
paternal chromatin shows demethylation within four hours after fertilization (Arney, Bao et al. 2002).
Nevertheless, only a few imprinting control centers are methylated in the male germ line (Delaval,
Govin et al. 2007). Following fertilization paternal imprinting, control centers have been found to be
protected from global demethylation by H4K20 and H3K9m3, as opposed to the unmethylated allele
which has H3K4m2 and H3 acetylation (Delaval, Govin et al. 2007). In the newly fertilized zygote, the
paternal pronucleus undergoes a complete remodeling as histones replace the sperm protamines.
Although maternal chromatin exhibits all three H3 methylation modifications, the newly remodeled
paternal chromatin receives unmodified histones from the zygote cytoplasm (Arney, Bao et al. 2002;
Cowell, Aucott et al. 2002). Methylated H3K9 is found only in the maternal chromatin, and thus is
completely absent in the paternal chromatin (Lepikhov and Walter 2004).
Obviously the regulation of DNA 5-methylcytosine and histone modifications are linked by
complexes of binding proteins, transcription factors and transferase enzymes (Guccione, Bassi et al.
2007; Ansari, Mishra et al. 2008). What is not known is whether one modification is dominant to the
other. In other words, do histone modifications direct DNA cytosine methylation, or vice versa? A well
known inverse link exist between DNA methylation and histone acetylation (Fuks 2005), yet there is
still controversy regarding the role of histone methylation (Gartler, Varadarajan et al. 2004; Umlauf,
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Goto et al. 2004; Zhang, Fatima et al. 2005; Zhao, Soejima et al. 2005). From the known data, there are
three logical possibilities for 5-methylcytosine and histone modification regulation and establishment:
common regulation/dependent, common regulation/independent or independent regulation/combination.
Common regulation /dependent represents a common regulator, with both 5-methyl-cytosine and
histone modifications being dependent on concurrent establishment. With common regulation
/independent, however, both 5-methylcytosine and histone modifications are under common regulation,
but the establishment could be independent of each other. Independent regulation is separate and retains
independent establishment. However, independent establishment does not rule out either of cooperation
or synergistic effects; for instance, 5-methylcytosine pattern formation may increase some histone
modifications.
Is DNA methylation the regulation that marks histones for modification, or is it the histones that
regulate DNA methylation patterns? In vitro fertilization (IVF) studies have shown that preimplantation embryos are sensitive to environmental manipulation (Fleming, Kwong et al. 2004). For
example, embryo culture conditions and culture media may change methylation patterns of imprinted
genes (Doherty, Mann et al. 2000). However, no changes in histone modifications (methylation,
acetylation, or phosphorylation) between in vitro and in vivo in mouse embryos have been detected
(Huang, Lei et al. 2007). In tumor suppressor gene studies, elimination of DNA methylation from
p16INK4a promoter resulted in marked changes in surrounding histones (Bachman, Park et al. 2003).
However, this study also found that histone modifications linked to tumor suppressor gene silencing can
occur independently of DNA methylation. The question still remains: Which comes first, DNA
methylation or histone modifications? More precisely, are the histone modifications regulating DNA
methylation and genetic imprinting, or are the 5 methylcytosine DNA modifications regulating histone
modifications?
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Numerous toxicants were reported such as industrial pollutants as well as naturally occurring
toxins causing genetic mutations and/or as cellular damage (Nyce 1997; Edwards and Myers 2007;
Hamon, Batsche et al. 2007). Chemicals such as benzene, dihalides, heavy metals, and tobacco smoke
were shown to cause genetic mutations and chromosomal aberrations, as well as reproductive problems
(Thier, Taylor et al. 1993; Wen, Meng et al. 2007; Xiong, Hu et al. 2007; Soares and Melo 2008; Wise,
Holmes et al. 2008). In one study, low-dose benzene was linked to aberrant DNA methylation patterns
such as hypermethylation in p15 and hypomethylation in MAGE-1. Low-dose airborne benzene
however, was not linked to loss of imprinting (LOI) (Bollati, Baccarelli et al. 2007). Benzo (a)pyrene
has been shown to alter H3K9 acetylation patterns in MCF7 breast cancer cells (Sadikovic, Andrews et
al. 2008). New research now shows that even bacterial toxins may induce changes in histone
modifications. L. monocytogenes modulates host gene expression by de-phosphorylation of H3-Ser10
and deacetylation of H4 by its secretion of a virulence factor listeriolysis (LLO) (Hamon, Batsche et al.
2007). Dephosphorylation of H3-Ser10 has also been shown to be a signature of two other toxins in the
LLO family. C. perfringens perfringolysin (PFO) and S. pneumonia pneumolysin (PLY).
Pneumolysin is the most intriguing of the toxins from pneumonia, remains a common infection.
The epigenetic effect on gametogenesis and embryogenesis following infection by S. pneumonia is
potentially dramatic. In this study, ten genes were selected at random to test the effect of gene
expression by LLO. Results showed that three were up-regulated, five were down-regulated and two
remained unchanged (Hamon, Batsche et al. 2007). In mice, tobacco smoke was linked to increased
mutation frequencies in spermatogonial stem cells (Yauk, Berndt et al. 2007). Research showed that
nickel chloride blocked histone acetylation in yeast (Ke, Davidson et al. 2006) and other researchers
showed the same affects in mammalian cells (Golebiowski and Kasprzak 2005). Changes in DNA
sequences may also affect the DNA 5-methylcytosine and/or the histone modifications patterns.
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The importance of studying the effects of EDC on male reproductive system is crucial to the health
of both the present and future generations. Unrepaired DNA lesions or de novo mutations in spermatogonial
stem cells are imparted systemically to the offspring. Even with ubiquitous human exposures to dihalides,
few gametogenic and reproductive studies have been done. Alkylating agents such as EDC can disrupt
heritable epigenetic information by many pathways. For example, dichloro-acids are commonly used in the
disinfection of drinking water, yet were shown to be developmentally toxic in mouse embryos (Andrews,
Nichols et al. 2004). While not directly disrupting epigenetics, endocrine disruptive chemicals can
indirectly alter genetic imprint patterns by blocking or sending false endocrine signals as well as affecting
endocrine organs (Greim 2004).
In vivo assays are the standard for reproductive and genetic toxicology assays. Because of
regulations it is not only becoming an increasingly cost prohibitive burden, but is also frowned upon by
the animal rights movement. Some people question if in vitro assays are reliable and efficient enough to
be used for reproductive and genetic toxicological assays (Lilienblum 2008). Yet the in vitro culture of
mouse embryo and spermatogonial stem cells has been well studied (Kubota, Avarbock et al. 2004; Shi,
Wang et al. 2006; Shen, Zhang et al. 2008). Current research shows that long term in vitro tissue
culture is a reliable way to propagate embryo and spermatogonial stem cells with certain limits due to
possibility of aneuploidy (Hayflick 1965; Kubota and Brinster 2006; Sun, Tao et al. 2008). What is not
yet known is whether in vitro culture of embryo and spermatogonial stem cells can be effectively used
for reproductive and genetic toxicolological assays. Can embryo stem cells be transformed into
spermatogonial stem cells reliably and with high efficiency? Can spermatogonial stem cells be
subcultured and cloned from a single cell or colony? Are embryo and spermatogonial stem cells
resilient enough to survive treatments with carcinogens and toxicants? Most importantly, will treated
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spermatogonial stem cells reliably and effectively trigger meiosis in order to establish the epigenetic
programming?
The initial step in this dissertation research was to determine whether or not EDC adversely
affects male reproductive functions. As described in Chapter 2, EDC produced dose-dependent
testicular pathology and sterility in male C57/BL mice. Subsequently, the approach entailed studying
the impact of EDC on the epigenetic patterns that constitute the paternal imprint. The paternal imprint
is established in pre-meiotic spermatogonia. In order to study these epigenetic patterns, an in vitro
culture model of spermatogonia stem cells and maturing pre-meiotic spermatogonia was required.
Chapter 3 describes the development and validation of the in vitro culture model for murine
spermatogonial stem cells and the induction of maturing pre-meiotic spermatogonia. It has been
proposed since 2004 that stem cells are the perfect in vitro model to test for both genetic and epigenetic
toxicology (Davila, Cezar et al. 2004). Finally, Chapter 4 describes this experimental approach and
results of studying the impact of EDC on the paternal imprint in murine pre-meiotic spermatogonia.
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CHAPTER 2
ETHYLENE DICHLORIDE DISRUPTION OF FERTILITY IN MALE MICE *
2.1 Introduction
Ethylene dichloride (EDC), also known as 1,2-dichloroethylene, is a high use chemical in
today's industry, for the synthesis of vinyl chloride, as a chlorinated solvent, and as a constituent in
paints, soaps, scouring compounds, and metal degreasers (ATSDR 2001). EDC has also been used
as an extracting solvent for spices and other natural flavorings, including tobacco. The production
of EDC in the United States was about 16 million tons in 1994 (ATSDR 2001). In Louisiana the
total EDC discharge for 1987 to 1993 was greater than 15 million pounds (LDEQ 1995).
EDC is a known mutagen requiring metabolic activation by glutathione conjugation.
Glutathione-dependant metabolites, such as S-(2-chloroethyl) glutathione and S-(2-chloroethyl)-Lcysteine, spontaneously rearrange to form reactive episulfonium ions that react with nucleophilc
sites on cellular macromolecules including DNA (Peterson, Harris et al. 1988; Romert, Magnusson
et al. 1990). The major DNA adduct formed from EDC is reported to be N7-ethyl-S-glutathionyl
deoxyguanosine (Romert, Magnusson et al. 1990; Cmarik, Humphreys et al. 1992). Interestingly,
the mutation spectrum produced by EDC and other dihaloethanes appears to be limited to G  A
transitions (Aafjes, van der Vijver et al. 1978; Cmarik, Humphreys et al. 1992). Since most tissues
contain glutathione and glutathione-S-transferase, EDC may react and damage multiple organs
systems including testis. The US EPA has designated EDC as a potential carcinogen, hazardous
substance, and priority toxic pollutant (EPA 2000). EDC is also designated as a possible human
carcinogen (Group 2B) by the International Agency for Cancer Research (IARC 2006).

*
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Early studies with EDC have reported little or no reproductive toxicity. Inhalation studies
showed only embryo toxicity at high doses and no significant reproductive toxicity (Lane, Riddle et
al. 1982). Rats and mice exposed to this highly volatile compound in drinking water or in diet
showed no effects on fertility (Alumot, Meidler et al. 1976) and lacked remarkable pathology in
reproductive tissues (Daniel, Robinson et al. 1994).
These reports of limited reproductive and testicular toxicity by EDC are surprising since tissues
with significant mitotic indexes are generally sensitive to reactive alkylating compounds, such as
the activated EDC-glutathione episulfonium ion. Mammalian gonadal tissues are well known to be
sensitive to cytotoxic agents. The loss of fertility in males due to chemotherapy has been well
documented (Chapman 1983; Meistrich 1984; Meistrich and Samuels 1985; Meistrich 1993). The
present study was undertaken to evaluate the effects intraperitoneal EDC on the fertility and
testicular tissue in male mice.
2.2 Material and Methods
Animals. Ten-week old male C57BL/6 mice were purchased from Charles River
Laboratories Inc. (Wilmington, MA). The mice were housed in an animal core facility in a
controlled temperature (22°C) and humidity (50%-60%) environment with greater than 10 complete
exchanges of filtered air per hour. Mice were also on a 12 hr light/dark cycle, and were fed
autoclaved commercial mouse chow (Purina Autoclavable Laboratory Chow 5010, Ralston-Purina,
St. Louis, MO) ad libitum. Males were housed four or five to a cage during acclimatization, and
then one to a cage at the beginning of the experiment. As excellent breeders with C57BL/6 males,
female Balb/c mice were obtained from the LSU School of Veterinary Medicine Animal Core
Facility’s breeding colony, and paired with males for fertility determinations.
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EDC (CAS No. 107-06-2) (99.8%) was purchased from Sigma-Aldrich (St. Louis, MO).
Each solution of EDC in corn oil was prepared fresh daily at concentrations necessary for
intraperitoneal (IP) injections of 0.1 ml per 10 g mouse weight. Sexually mature (greater than 11
weeks of age) male C57BL/6 mice received five IP injections, one per day for five consecutive days
(Figure 2.1). Fertility determinations utilized groups of three male mice per dose reported. Mice
received a dose of 5 to 40 mg/kg of EDC or vehicle, with each IP injection, and subsequently held
for 45 days to allow for complete turn over of spermatogenesis (Drost and Lee 1995) (Table 2.1).
Males were then paired with Balb/c females to determine fertility. Males were determined to be
permanently sterile if found to be infertile for six months or longer. Permanently sterile males and
male mice that recovered to fertility were euthanized by CO2 asphyxiation only after siring two
consecutive litters (Figure 2.1). Upon sacrifice, the testes and epididymides were surgically
excised carefully to reduce crush artifact, and immersed in formalin for subsequent pathological and
histological analyses.
A separate experiment designed to determine the early testicular pathological effects of EDC
was performed with the same dosing protocol above using 10 mg/kg. Controls received IP
injections of the vehicle (corn oil) only. Following the five days of dosing, one to three male
C57BL/6 mice were euthanized at each time interval post treatment of 8, 15, 31, and 46 days, and
the testicular pathology assessed (Table 2.2).
Pathology. Hematoxylan and eosin stained sections of paraffin embedded, formalin fixed
testis were analyzed for the total number of Sertoli cell-only (SCO) tubules, and Leydig cell counts,
for each testis examined. For percent SCO determinations, between 130 and 300 separate tubules
(248 tubules per testis on average) in each testis preparation were examined for the presence or
absence of spermatogenic cells (spermatogonia, spermatocytes, spermatids and spermatozoa) in
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addition to Sertoli cells. Leydig cells were counted in five randomly chosen high power
microscopic fields (1.77 mm2) and the average cell count reported for each testis studied.
Individual testes were also given a Spermatogenesis Score. The scoring system published
by Johnsen (17) is based on human testicular evaluation. Mouse spermatogenic stages are arranged
in relatively linear manner compared to the helical pattern observed in humans. However, the
random evaluation of twenty seminiferous tubules per histological testicular cross-section should
normalize these species differences and provide an appropriate scoring system to compare changes
in testicular functions. Using the criteria of Johnsen (17) as modified by Aafjes et al. (18),
hematoxylan and eosin stained sections of paraffin embedded, formalin fixed testis were scored on a
10 point scale assessing the extent of spermatogenesis. Twenty randomly chosen seminiferous
tubules were evaluated utilizing the testicular scoring protocol below:
10:

Complete spermatogenesis

9:

Many spermatozoa present, but germinal epithelium disorganized with marked
sloughing or obliteration of lumen

8:

All stages of spermatogenesis present, but fewer than 5-10 spermatozoa present

7:

No spermatozoa, but many spermatids present

6:

No spermatozoa, but fewer than 5-10 spermatids present

5:

No spermatozoa, no spermatids, but many spermatocytes present

4:

No spermatozoa, no spermatids, but fewer than 5 spermatocytes present

3:

Only spermatogonia present

2:

Sertoli cells only

1:

No cells in tubular cross section.
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Statistical Analysis. Statistical analysis was performed using the unpaired, two-tailed t test for
differences between treated and control percentages of SCO tubules and Leydig cell counts. The
linear plot for Leydig cell counts was determined using a Least Squares fit within 95% confidence
interval. The criterion for significance for all tests was P ≤ 0.05.
2.3 Results
Sexually mature male C57BL/6 mice were treated daily with IP injections of EDC in corn
oil at doses of 0, 5, 10, 20 and 40 mg/kg for five days (Table 2.1). The dosing range for these
experiments was chosen based on the literature. Short-term doses of 40 mg EDC/kg and lower were
not anticipated to produce substantial systemic toxicity in mice; LD50 for mice is reported to be 489
mg/kg of body weight (ATSDR 2001). In the present studies, mice treated with EDC showed no
obvious toxicity even at the 40 mg/kg dose. Weight gain was consistent and matched controls
throughout treatment time period and throughout the study. No loss of hair or any obvious lesions
were noticed. Treated mice appeared normal with no sign of disorientation or lethargic behavior.
These treated mice maintained a healthy normal appearance for the rest of the study, with the
exception of one mouse (10 mg/kg dose) that died during week 13 post treatment of undetermined
cause. A gross survey of organs and tissues did not discern an obvious cause of death or other
notable injuries attributable to the EDC treatment.
Since spermatogenesis was active at the time treatment began, mice were held for 45 days
after the end of the five day treatment to allow for complete turnover of spermatogenesis prior to
testing for fertility (Drost and Lee 1995) (Figure 2.1). This experimental protocol was designed to
enable the determination of the effects of EDC on the early stages of spermatogenesis without the
interference of mature sperm or maturing sperm that may have been collected and retained in the
caudal epididymides and vas deferens during and shortly after treatment.
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Thus, 45 days post EDC treatment males were paired with female mice to determine fertility
(Figure 2.1). Unexpectedly, one male from each of the 20 mg/kg and 5 mg/kg groups sired a litter
of six offspring immediately after being paired with female mice and were subsequently found to be
permanently sterile or sterile for a brief period, respectively (see Table 2.1). The 5 mg EDC/kg
treatment group was the only dosing group where mice recovered to fertility after a brief sterile
period (Table 2. 1).
Male mice were euthanized by CO2 asphyxiation after siring two consecutive litters or
determined to be permanently sterile. For all mice, gross examination of liver, brain and kidney
tissues showed no obvious effects from EDC. Testicular tissue was examined for 0, 5, and 10
mg/kg doses. The testes were atrophic and the epididymides were shrunken and deflated in the
sterile mice sacrificed at 270 days post treatment, for both EDC dose levels of 5 and 10 mg/kg.
Histological analyses consistently displayed hypocellular tubules lacking spermatocytes and
spermatogonia, and prominent vacuolization including Sertoli cells, while Leydig cells were evident
(Figure 2.2).
A more promising testicular pathology was observed from the two males treated with 5 mg
EDC/kg that recovered to fertility after a 3 and 5 week sterile period, respectively, prior to sacrifice
at 120 days (see Table 2.1). Histological analyses of testes from fertility-recovered males displayed
active spermatogenesis among tubules with pleomorphism and hyperchromasia of spermatocytes
and spermatogonia as compared to controls (Figure 2.3). Other tubules displayed disruption of
spermatogenesis and significant apoptotic processes.
A short-term study was performed to determine the time course of the development of
testicular pathology. Male mice were treated with 10 mg EDC/kg or vehicle under the same fiveday treatment protocol above, and sacrificed at intervals of 8, 15, 31, and 46 days post treatment.
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EDC induced adverse pathology was evident as early as 8 days post treatment (Figure 2.4). It
appears that EDC may have induced an arrest in spermatogenesis with subsequently developing
tubular germ cell aplasia within 8 days. Tubular damage, marked vacuolization of cells and loss of
spermatogonia was detectable at 8 days and deteriorated with longer time periods post dose
(Figures 2.2, 2.3 & 2.4). However, Leydig and Sertoli cells were consistently present in these
histology sections.
As indicators of testicular pathology, histologic preparations from mouse testes were
examined for Leydig cell counts, percentage of seminiferous tubules that are SCO, and scored based
on spermatogenic activity (17,18). Analyses of testicular tissue from all of the mice treated with
EDC displayed numerous Leydig cells in the intertubular interstitial spaces. Based on EDC dose,
testes from the 5 mg/kg treated mice contained significantly more Leydig cells than controls (P <
0.041) while the 10 mg/kg treated mice were not significantly different from controls (Table 2.2).
However, this lack of dose response effect may have been biased by time effects post treatment.
Based on time post treatment, testicular preparations from EDC treated mice sacrificed equal to or
greater than 120 days contained significantly more Leydig cells than preparations from EDC treated
mice sacrificed less than 120 days (51.0 ± 9.5 (n=5) vs. 34.7 ± 4.0 (n=6); P< 0.004), and from
control mice (38.5 ± 6.4 (n=8); P< 0.016). As these mouse experiments were established for
clinical fertility determinations, none of the control mice were carried out to 120 days or longer.
Control Leydig cell counts ranged from 30 to 45, which was similar to the less than 120 day EDC
treated mice. This EDC time post treatment effect on increasing Leydig cell numbers is more
clearly seen in a Least Squares curve fit analysis of a scatter plot (see Figure 2.5).
Sertoli cells also appeared to be resilient to the damaging effects of EDC as these cells were
consistently present in testicular preparations from all of the treated mice. Seminiferous tubules
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from each testis were analyzed for the presence of Sertoli cells and the loss of developing
spermatogonia and spermatozoa, providing the recorded result of percent of the tubules that are
SCO. Testicular preparations from both 5 and 10 mg/kg EDC treatment groups displayed
significantly more SCO tubules than controls (P< 0.04 and P<0.0002, respectively) (Figure 2.6).
Testes from mice treated with 5 mg EDC/kg ranged from 2% to 36% SCO, the 36% corresponding
to the one mouse at this dose that was found to be permanently sterile, while the controls ranged
from 0% to 4% SCO. Similarly, testes from mice treated with EDC at 10 mg/kg ranged from 7% to
22%, with the highest values corresponding to mice euthanized after 270 days, suggesting a time
post treatment effect. Testicular preparations obtained from mice treated with EDC and euthanized
120 days or later harbored significantly more SCO tubules than EDC treated mice sacrificed less
than 120 days (22.8 ± 11.9 (n=5) vs. 8.67 ± 1.63 (n=6); P< 0.017). However, both of these EDC
treatment groups were significantly different than controls (1.56 ± 1.52 (n=8); P< 0.0003 and P<
0.0001, respectively), even though the controls were sacrificed in the same time frame as the latter
EDC treated group, less than 120 days post treatment. The impact of 10 mg/kg of EDC treatment
was observable as early as 8 days post treatment with the testis displaying 7% SCO tubules
(Figures 4 & 6). Interestingly, testicular damage remained at a similar level throughout a 46-day
post treatment time course, as testes obtained from EDC treated males 15, 31 and 46 days post 10
mg/kg dose displayed 7% to 11% SCO tubules.
EDC induced adverse pathology was evident within 8 days post dose and reached a plateau
throughout 15 to 46 days. Using the standard methods for the evaluation of cellular activities and
structural integrity, testes were given a pathology score. As early as 8 days post treatment with 10
mg/kg of EDC the testis displayed a reduced score of 8.35. Controls provided testicular pathology
scores ranging from 8.85 to 9.85 (average 9.46). Testes obtained from males 15 to 46 days post 10
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mg/kg treatment displayed scores ranging from 6.40 to 7.40, which were similar to the scores of
sterile males (10 mg/kg dose) carried for 9 months (270 days). Comparing all testicular specimens
together demonstrated a direct response to EDC and decreased spermatogenesis (Figure 2.6). The
testis score decreased significantly with EDC doses of 5 and 10 mg/kg (P< 0.0001) compared to
controls. The time course of the effect on testicular damage and the testis score is clearly displayed
in a Spline curve of the combined 5 and 10 mg/kg treatment groups (Figure 2.7).
2.4 Discussion
Reproductive toxicity has not been previously associated with EDC, a heavily used
industrial chemical (WHO 1987; ATSDR 2001). The present experimental results suggest that
EDC may potentially affect the mammalian testes resulting in partial loss of germ cells and
decreased fertility. Short-term IP doses of 10 mg EDC/kg, daily for five days, rendered male
C57BL/6 mice sterile for at least 9 months. Previous reports on the lack of reproductive toxicity
utilized drinking water and diet as a route of exposure (8 – 11). It is possible that the concentrations
of EDC in the food and water were over estimated due to the high volatility of this compound.
Alternatively, the intraperitoneal injection route may bias the distribution of EDC in such a way as
to enhance the concentrations of EDC that reach the testes. Further studies will be necessary to
clarify these issues and to determine the presence of any reproductive health risks to mammals or
humans from EDC by other routes of exposure.
The sensitivity of the mammalian testis and germ cells to EDC may also be a function of the
dose-rate due to the accumulation of damage produced by each daily exposure (Boekelheide and
Eveleth 1988). The sensitivity of the human testis to the toxic effects of EDC as compared to the
mouse is not currently known, although infertility-inducing doses of chemotherapeutic drugs are
similar in man and mouse (Meistrich 1993; Seaman, Sawhney et al. 2003).
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Activation of EDC occurs by glutathione conjugation, producing a highly reactive
episulfonium ion (Romert, Magnusson et al. 1990; Cmarik, Humphreys et al. 1992). With the
possible exception of the latter stages of maturing germ cells, most of the cells of the testes contain
glutathione and express one or more glutathione-S-transferases, so that EDC is readily activated in
the testes. The testicular toxic impact of EDC could result from targeting germ cells, Sertoli cells or
Leydig cells. The sensitivity of germ cells to the direct actions of alkylating agents depends on the
stage of maturation, such that dividing pre-meiotic spermatogonia may be much more susceptible to
lethal effects of EDC than post-meiotic spermatids which no longer actively replicate DNA, are
repair-deficient, and begin to condense chromatin. Alternatively, disruption of the Sertoli cell
function by EDC may lead to a precipitous and persistent loss of germ cells. Diminished production
of cytokines and other factors (e.g. leukemia inhibitory factor (LIF) and bone morphogenic protein4 (BMP4)) will lead to spermatogonial stem cells losing their self-replacement character and
becoming committed spermatogonia cells (Pellegrini, Grimaldi et al. 2003; Ying, Nichols et al.
2003; Lacham-Kaplan 2004). Early differentiation committed germ cells, spermatogonia A1 – A4
stages and above, require stem cell factor (SCF) and the nurturing of selective seminiferous fluid
constituents produced by Sertoli cells near the basal membrane of the seminiferous tubule (Rossi,
Sette et al. 2000; Sette, Dolci et al. 2000). Adhesion proteins specific for Sertoli cell-germ cell
attachment may also be required for germ cell survival and maturation (Beall, Boekelheide et al.
2005). Disturbing Leydig cell testosterone production may perturb the hypothalamic-pituitary-testis
axis and gonadotropic hormone balance, leading to loss of spermatogenesis and testicular atrophy
(Cook, Klinefelter et al. 1999). The continued presence and health of Leydig cells in atrophic
testes from sterile mice argues against this mode of action by EDC. However, Leydig cell
hyperplasia, as observed in the present study, has also been reported in response to other alkylating
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agents and may be the result of indirect long-term hormonal feedback due to limited or lack of
spermatogenesis in the testes (30,31).
The present experimental results demonstrated the survival of both Sertoli cells and Leydig
cells despite persistent and prolonged testicular damage initiated by EDC. This suggests that if
either of these two cell types was targeted by EDC, the greatest impact was on Sertoli cellular
function and the subsequent loss of maintenance and maturation of germ cells. Based on testicular
pathology, the damage induced by EDC was complete within the first 8 days. This protracted
atrophic effect on spermatogenesis was most likely due to a significant loss of required factors and
the environmental niche of seminiferous fluid constituents, and/or close Sertoli cell-germ cell
association. Lack of maintenance of spermatogonial stem cells as self-replacing germ stem cells
would lead to an ultimate loss of germ cells, since spermatogonial stem cells would become
differentiation committed spermatogonia A1 or B cells. The result is the same whether increased
apoptotic pressure induced loss of germ cells during maturation, or by direct lethal alkylation
damage to stem cells. However, spermatogonial stem cells have a slow cell cycle rate of 8 or more
days in the testes, allowing time for significant DNA repair prior to DNA replication and division,
making direct cell killing by EDC alkylation less likely (Meistrich 1984; Schoenfeld, Hall et al.
2001). It is possible that the careful determination of which stage(s) of spermatogonia are initially
diminished by EDC may provide more clarification of the mechanism by which EDC disrupts
spermatogenesis.
Doses of EDC at 5 mg/kg produced sterile periods of several weeks in two of three treated
male mice, suggesting that recovery and repopulation of the seminiferous tubules with
spermatogonial stem cells is possible at lower doses. Similar dose-dependent recovery of
spermatogenesis in mice has been described for cis-platinum (Pogach, Lee et al. 1989), neutron
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radiation (van Beek, Meistrich et al. 1990), 2.5-hexanedione (Boekelheide 1988), mono-2ethylhexyl phthalate (Richburg and Boekelheide 1996), and in humans treated with
chemotherapeutic agents (Meistrich 1984).
EDC is a potent mutagen and could initiate mutations in replicating germ cells. The closely
related compound, 2-chloroethyl methanesulfonate, that also forms the same structural DNA
adducts as EDC via an episulfonium ion following activation by glutathione, has been shown to be a
potent germ cell mutagen in Drosophila melanogaster (Fossett, Byrne et al. 1995; Fossett, Byrne et
al. 1996). Germ line mutagenesis has been demonstrated for 2-bromoethane and EDC in
Drosophila (Kramers, Mout et al. 1991). It is also interesting to note that two offspring in the last
litter sired by one of the fertility-recovered males (5 mg/kg group) were severely deformed.
However, the potential risk for EDC initiated increases in germ line mutagenesis in humans is
unknown and perhaps less probable (Wyrobek, Mulvihill et al. 2007).
The present study suggests that EDC administered IP is toxic to the testes and
spermatogenesis in mice. Similar testicular toxicity might well be a property of the class of
dihaloethanes. More research is needed to determine the mode of disruption of spermatogenesis,
loss of germ stem cells and protracted testicular damage, as well as the impact of the route of
exposure on this testicular toxicity. Titration of the dose of EDC used in this 5-day treatment
regimen enabling fertility-recovery and expansion of surviving spermatogonial stem cells may
provide an additional model for the study of germ cells at all stages of maturation and their
susceptibilities to toxic actions of chemicals. With the progressive loss of spermatogonia, but not
the Sertoli cells from tubules, the pathology has similarities to the testicular dysgenesis syndrome in
the human clinic (Skakkebaek, Rajpert-De Meyts et al. 2001), and possibly to a nonheritable,
environmentally acquired Sertoli Cell-Only Syndrome (Anniballo, Ubaldi et al. 2000).
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2.5 List of Abbreviations
EDC, Ethylene dichloride
SCO, Sertoli Cell-Only
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2.7 Experimental Data
Table 1. Fertility Results in Mice Exposed to EDC
Dosage a Sterile Period b
(mg/Kg)
0

None (Fertile)

5

3 weeks (one mouse),
5 weeks (one mouse),
Permanently Sterile (one mouse), sterile for 270 days post treatment

10

Permanently Sterile (2 mice c), sterile for 270 days post treatment

20

Permanently Sterile (all 3 mice), sterile for 180 days post treatment

40

Permanently Sterile (all 3 mice), sterile for 180 days post treatment

a

Three mice per dose group, except for control (zero dose, corn oil only) which
contained four mice. Each male mouse received 5 ip doses, one per day for 5
days.
b
Following a 45 day post treatment holding time, male mice were housed with
fertile female mice until determined to be fertile or permanently sterile (see
Materials and Methods).
c
One mouse died during week 13 of unknown causes (see text)
Table 2. Leydig Cell Counts in Mice Exposed to EDC
Dosag Leydig Cells b
P value c
ea
(mg/K
g)
0

38.5 ± 6.4 (8) d

--------

5

51.3 ± 11.7 (3)

P< 0.041

10

38.6 ± 8.8 (8)

P= 0.975

a

Each male mouse received 5 ip doses, one per day for 5 days.
Average number of Leydig cells present in five randomly chosen high powered microscopic
fields.
c
Comparison with controls.
d
Mean ± standard deviation, (number of mice analyzed)
b
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Figure 1. Flow chart for experimental treatment and fertility testing of mice. Sexually
mature male mice received 5 IP injections, one a day for 5 days, and then allowed to rest
for 45 days for complete spermatogenesis turnover. Males were then housed with
female mice to establish fertility. Mice were euthanized after siring 2 consecutive litters
of pups or after found to be sterile for 6 months or longer.
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Figure 2. Testis histological sections from a mouse determined to be sterile for 9 months
following treatment with 5 mg EDC/kg. (A) Section at 100x magnification, this section
displays the disruption of interstitial collagenous tissue, preservation of Leydig cells and
loss of spermatogonia in many tubules, where vacuolization is prominent, signifying
cellular damage. (B) At 400x magnification, this tubule shows rare spermatogonia and
vacuolar change of Sertoli cells; note the intact Leydig cells adjacent to the tubule.
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Figure 3. Testis histological sections from (A & C) normal control (0 mg/kg) mouse, and (B &
D) 5 mg/kg treated mouse that recovered to fertility following a sterile period of 5 weeks,
exhibiting noticeable differences in spermatogenesis. Note on scanning magnification the loss of
cellularity, loss of adhesion amongst the tubules and interstitial tissue, and increased number of
dilated seminferous tubules in the EDC treated mouse (B) compared to the densely packed
seminferous tubules of the normal control mouse (A) (20x magnification). At 400x
magnification, the normal control mouse shows complete, organized spermatogenesis with
numerous spermatozoa (C); whereas, the EDC treated mouse shows disruption of
spermatogenesis with loss of spermatozoa and spermatids, and scattered apoptotic bodies (D).
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Figure 4. Testis histological sections from a 10 mg EDC/kg mouse euthanized only 8 days after
treatment. (A) Section at 100x magnification, sections display tubular damage and disruption of
testicular structure. (B) At 200x magnification, two central Sertoli Cell-Only tubules show
marked vacuolization (and loss of spermatogonia).
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Figure 5. Plot of testicular Leydig cell counts versus the time post EDC treatment that mice
were euthanized. Both 5 and 10 mg/kg treatment groups are included. The linear curve was
determined by a Least Squares fit analyis (r = 0.74, P = 0.009).
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Figure 6. Dose response effects of EDC on testicular pathology. The Testes Score (light grey)
decreased with EDC treatment, while the percentage of tubules that only contained Sertoli cells
(dark grey) increased. The time post treatment that testes were harvested from mice following
euthanization, ranged from 8 to 270 days. Two of the mice in the 5 mg/kg EDC treatment group
recovered fertility prior to harvest at 120 days. The number (n) of testes (one per male mouse)
in each treatment group is denoted above the bars. A single asterisk (*) indicates that the Testis
Scores for the 5 and 10 mg/kg EDC treatment groups were significantly different (p< 0.0001)
from controls (0 mg/kg EDC). A double asterisk (**) and triple asterisk (***) indicates that the
percent of SCO tubules were significantly elevated (P< 0.04 and P< 0.0002, respectively) from
controls.
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Figure 7. Spline curve demonstrating the effect of EDC on spermatogenesis over time. Spline
curve was derived from the combined data of both 5 mg/kg and 10 mg/kg treated mice. This is a
median Spline curve calculated by obtaining cross medians, which are used as knots to fit a
cubic spline that is graphed as line plot. Insert photo shows two seminferous tubules from a 5
mg/kg treated mouse that was sacrificed at 120 days, one (top) with sloughed necrotic material
and spermatogonia only (score 3), and the other (bottom) with few spermatozoa and all stages of
spermatogenesis (score 8).

43

CHAPTER 3
DEVELOPMENT OF THE IN VITRO MOUSE SPERMATOGONIAL
STEM CELL CULTURE MODEL
In order to study the potential impact of EDC on the paternal imprint, germ cells containing
the normal or perturbed DNA imprint must be isolatable to a reasonable purity. Although mature
spermatozoa are easily accessible in semen specimens, the prolonged maturation time in
spermatogenesis and storage prior to ejaculation leads to difficulties in studying acute effects of
toxicants on the paternal imprint. Obtaining sufficient numbers of the correct stage of
spermatogonia from resected testes after acute in vivo EDC exposure is complicated by the mixture
of germ cells at all stages of spermatogenesis. The paternal imprint is established in spermatogonial
stem cells or in early stage differentiating spermatogonia A cells prior to meiosis. The development
of an in vitro model system that enables the stable culturing of spermatogonial stem cells and
triggering of spermatogenesis, without the use of a „feeder‟ layer, would provide an ability to
perform acute exposure experiments, thus making available analyses of specific epigenetic patterns
in DNA from a high purity of germ cells at the appropriate stage of maturation.
The value of in vitro models resides in the ability to mimic in vivo conditions while
limiting the complexity of the cellular system under study. Previous reports to date have
emphasized the need to use feeder cultures in order to grow and differentiate mammalian
spermatogonial stem (As) cells (Nayernia, Lee et al. 2006; Nayernia, Nolte et al. 2006). Recent
reports by Nayernia et al. (2006a; 2006b) have shown that mouse embryonic stem (MES) cells
can differentiate into primordial germ cells (PGC) and finally into early gametes and
blastocysts. While little is known about the As cellular niche with Sertoli Cell (De Rooij 2009),
advances have been made in the use of growth factors that influence stem cell behavior and
differentiation (Lee, Kanatsu-Shinohara et al. 2008). Established protocols have demonstrated
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that human and mouse embryo stem cells can be maintained undifferentiated long term in the
presence of LIF (Penkov, Platonov et al. 2003; Furue, Okamoto et al. 2005), and LIF has been
shown to enhance germ cell clonal populations in mouse testis (Kanatsu-Shinohara, Inoue et al.
2007). Spermatogonial stem cells (As cells) however, are inhibited by LIF and require a
different set of growth factors. Glial cell line-Derived Neurotrophic Factor (GDNF), a
transforming growth factor-ß (TGFß) family member, has been shown to be a critical growth
factor for mouse As cell renewal and is thought to be conserved throughout all mammalian
species (Ryu, Kubota et al. 2005; Lee, Kanatsu-Shinohara et al. 2008). In vitro mouse As cells
cultured with GDNF up regulate transcription factors Bc16b, Erm and Lhx1 through Src Family
Kinase signaling. GDNF activates these transcription factor genes through the P13K/Akt
signaling pathway which is essential for As cell “general” survival and propagation in vitro
(Oatley, Avarbock et al. 2007). Over expression of GDNF in mouse testes appeared to stimulate
self-renewal of stem cells and block spermatogonial differentiation (Meng, Lindahl et al. 2000;
Kubota, Avarbock et al. 2004). After long term (over two years) in vitro culture using GDNF,
mouse As cells remained genetically stable (Kanatsu-Shinohara, Ogonuki et al. 2005).
Bone morphogenetic protein, Bmp 4, has been shown to be critical for differentiation of
embryo stem cells to As cells, along with the maintenance of spermatogenesis (Zhao, Liaw et al.
1998; Lawson, Dunn et al. 1999; Ying, Liu et al. 2000; Baughman and Geijsen 2005). Bmp4, a
member of the TGFß super family, is required for primordial germ cell renewal in mouse
(Lawson, Dunn et al. 1999). Bmp4 is a dimer that signals through heteromeric receptor
complexes and downstream SMAD pathways (Shimasaki, Moore et al. 2004). Mice that are
Bmp4 null fail to generate and propagate primordial germ cells, and heterozygous mouse
embryos for the null mutation show approximately 50% primordial germ cell populations
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compared to wild type mice. The implication being that Bmp4 is not only required primordial
germ cell generation, but is dose dependent as well (Lawson, Dunn et al. 1999).
Bmp8b is a member of the Gbb-60A class of the bone morphogenetic protein BMP
family. Bmp8b has not been shown to be vital to the generation of primordial germ cells, and it
may not be required for proliferation or survival (Ying, Liu et al. 2000). Although, it has been
determined that Bmp4 and Bmp8b together influence the size of the initial populations of
primordial germ cells, the effects of Bmp4 and Bmp8b are not additive (Ying, Liu et al. 2000).
Stable, self-renewing As cells can be induced to terminally differentiate into the meiotic
spermatogenesis pathway. Previous in vitro studies have shown that retinoic acid (RA) triggers
As differentiation and allows spermatogonia to enter into and progress through meiotic prophase
I (Leid, Kastner et al. 1992; Bowles, Knight et al. 2006; Nayernia, Nolte et al. 2006). RA
appears to trigger a molecular cascade, inducing meiosis-specific genes such as Stra8, Scp3 and
Dmc1 (Koubova, Menke et al. 2006). In mature, vitamin A-deficient mice, where only
spermatogonia are found in the testis, the addition of RA has been shown to initiate the
resumption of spermatogenesis (Baleato, Aitken et al. 2005).
3.1 Mouse Germ Cell In Vitro Cultures
The present experimental work was undertaken to find a combination of selective growth
factors and culture conditions that will optimize the growth and preparation of pure cultures of
spermatogonial stem cells and meiosis-committed early stage spermatogonia, without the use of
feeder layers. Mouse C57BL/6 embryo stem cells (SCRC-1002) were purchased from ATCC
(Rockville, MD) and cultured according to the protocol for embryo stem cell self-renewal
(Kubota, Avarbock et al. 2004). MES cells are well known to freely propagate without a feeder
cell layer (Kanatsu-Shinohara, Inoue et al. 2006). MES cells were seeded at 8 ~10 x 105 cells per
T25 flask and grown in StemPro-34 SFM (Invitrogen, L.A., CA) medium supplemented
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with1% FBS (Invitrogen, L.,A., CA), 5% non-essential amino acids (Invitrogen), GlutaMAX
(Invitrogen), 5 mM 2-mercaptoethanol (Sigma, St. Louis, MO), 2% penicillin-streptomycin
(Invitrogen, L.A., CA), and 1,000 units of LIF (Chemicon Burllington, MS), in the presence of
a 5% CO2 atmosphere at 37oC. Undifferentiated MES cells cultured on plastic tended to pile in
clusters (fig. 3.1).

Figure 3.1. Mouse Embryo Stem (MES) Cells. These cells are grown on a plastic T25 flask,
according to media conditions noted in text.
The undifferentiated status of MES cells was moitored by the use of cellular expression
antigenic markers. These cultured MES cells expressed high levels of the POU transcription
factor, Octamer-4 (Oct-4) (see Figure 2.2). As has been previously reported (Pesce, Gross et.al.
1998) MES cells also express SSEA1, a cell surface carbohydrate antigen (Shevinsky, Knowles
et al. 1982), but not CD9, SSEA3, SSEA4, the laminin receptor components Alpha 6 and Beta1
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intergrin or GFRA1 (Kanatsu-Shinohara, Inoue et.a. 2004; Kanatsu-Shinohara, Toyokuni et
al.2004; Kanatsu-Shinohara, Niki et al. 2005). The in vitro differentiation of MES cells is
characterized by the loss of both Oct-4 and SSEA1, and the apperance of either SSEA3 and/or
SSEA4 (Solter, Shevinsky et al. 1997). Differentiated MES cells did not express CD 9
(Figure3.2).

Figure 3.2. Photographs of Cultured Cells. Cultured MES cells, spermatogonial stem cells, and
meiosis-committed spermatogonia, and fluorescent tagged antibody labeling of cell
developmental markers Oct 4, CD 9, and c-Kit.
3.2 Spermatogonial Stem Cells
The differentiation of MES cells and the isolation of spermatogonial stem, As cells, was
accomplished by the removal of LIF from the growth media and the addition of 10 ng/ml GDNF
(Invitrogen), and 50 ng/ml each Bmp4 and Bmp8b (see Fig. 3.2) After two weeks, these cells
tested positive for CD 9 and negative for both Oct 4 and c-Kit. The isolation and self-renewal
maintenance of As cells was monitored by the loss of Oct 4 and c-Kit expression and the

48

presence of CD 9 expression (see Fig. 3.2). Cells expressing CD 9 were differentiated from
pleuripotent MES cells to germline stem cells (Kanatsu-Shinohara, Toyokuni et al. 2004). The
combination of loss of Oct-4 and SSEA-1, together with the gain of expression of CD 9, SSEA3, SSEA-4, GFRA1, and/or alpha6 and beta1 integrins provides a positive identification of As
cells (Pesce et al. 1998; Kubota, Avarbock et al. 2004;(Solter and Knowles 1979; Yoshida,
Takakura et al. 2004).
Mouse As cells have been reported to preferentially attach to laminin (Yoshida, Takakura
et al. 2004). The present results show that mouse As cells attach and propagate well directly on
plastic. However, there was an initial delay in the growth of the cells. After two weeks with
very little growth (0.007 ± 0.012 PD per day (n=3)), cells showed slow growth with population
doubling (PD) times of 10.4 days (or 0.096 ± 0.055 PD per day (n=3). MES cells demonstrated
an average population doubling time of 2.7 days (or 0.37 ± 0.13 PD per day (n=3)).
Upon the differentiation of MES cells and monitoring using spermatogonial stem cell
marker CD 9 , As cells were easily subcultured into flasks and clonally expanded for study and
analyses. If these As cells can be induced to differentiate into meiosis-committed
spermatogonia, then this will be an excellent model for assaying the impact of toxicants such as
EDC on germ cells and the establishment of the paternal imprint.
3.3 Early Stage Spermatogonia
Viable mouse As cells should be responsive to the signal to differentiate into early stage
spermatogonia (Aal) and subsequently, the meiotic spermatogenesis pathway (de Rooij 2001).
Following the expansion of As cells, the flasks were washed three times with PBS, and media
containing RA (8µM) (Sigma-Aldrich, St. Louis, MO) was added to trigger the meiotic pathway
(Farini, Scaldaferri et al. 2005). Shortly after the addition of RA, these cells appeared to slow in
49

growth and become quiescent. No cell division was observed during the 14 days following the
addition of RA. After two weeks on RA containing media, these cells no longer expressed CD 9,
but now expressed c-Kit (also called CD117) (see Fig. 3.2). The expression of c-Kit
demonstrated the conversion of these As cells into pre-meiotic Aal spermatogonia. The protooncogene c-Kit is expressed in maturing spermatogonia and is the best cell surface maker for
initiation of meiosis in spermatogenesis (Meng, Lindahl et al. 2000). The product of c-Kit is a 150
kDa tyrosine-kinase receptor that is in the same family as α / β PDGF receptors and the CSF-1
receptor (Rossi, Sette et al. 2000). The ligand, Stem Cell Factor (SCF), is expressed by Sertoli
cells in mice (Rossi, Albanesi et al. 1991; Marziali, Lazzaro et al. 1993). Expression of c-Kit is
high in all stages of primordial germ cell migration, then disappears in As cells and returns in
differentiating A1-A4 spermatogonia (Lacham-Kaplan 2004). Other markers for initiation of
meiosis such as Vasa, Mil2 and Stella would have given me more confidence and will be used in
future research. Point mutations in the c-Kit gene impair the SCF-mediated activation of
phosphatidylinositol-3 kinase, but do not cause reduction in either primordial germ cells during

embryonic development or As cell populations. However, males are completely sterile due to a
block in DNA synthesis in differentiating Aal spermatogonia (Rossi, Sette et al. 2000).
Advances in the study of the molecular mechanisms involved in disease processes and
the perturbation of heritable programming components of germ cells has been hampered by the
complexity of the physiological system requiring the presence of multiple cell types. The present
work demonstrates the ability to isolate and expand As cells prior to the induction of early stage
spermatogenesis.
3.4 Materials and Methods
Mouse embryo stem cells (cell line ES-C57BL/6) were purchased from ATCC (SCRC1002) (Rockville, MD) and sub cultured according to ATCC protocols (product information
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sheet). Cryoprotectant media from ATCC. MES cells were seeded at 8 ~10 x 105 cells per T25
flask and grown in StemPro-34 SFM with supplements (Invitrogen, L.A., CA). Briefly, MES
cells were subcultured on non-coated Falcon T-25 flask and grown on commercial media
available from Invitrogen , StemPro-34 SFM with supplement (Invitrogen# 10639-011), and the
published protocol for embryo stem cell self-renewal (Kubota, Avarbock et al. 2004). Nonessential amino acids 1% (Invitrogen # 11140-050), GlutaMAX 1% (Invitrogen # 35050-061),
Penicillin-Streptomycin 1% (Invitrogen# 15140-148), 2-mercaptoethanol (Sigma# M7522100ML), 1% FBS (Invitrogen# 16000077). Leukemia Inhibitory Factor (Chemicon cat#
LIF2010) at 1000 units/ml(Penkov, Platonov et al. 2003). MES cells where subcultured
approximately 3 days. MES cells were subcultured approximately every three days after
doubling of population using protease, 1 µl/25 ml of media. Cells were washed three times with
phosphorylated buffer solution then treated with protease. Cells were re-seeded at one SCC
cluster per T-25 flask and fed using SCC media.
Spermatogonial stem cell differentiation media Stem Pro-34 SFM media with the same
supplements as MES cell media except with Bmp4 (Spring Bioscience #P7909) and Bmp8b at 50
ng/ml (Novus Biological #H00000656-Q01), GDNF at 100 ng/ml (Invitrogen #10907012). EDC
treated cells were treated with EDC (Sigma # 03522-500ml) at 5mM/ml. SCC where subcultured
on Falcon T-25 flasks. SCC were subcultured every two weeks after doubling of population using
protease, 1 µl/25 ml of media. Cells were washed three times with phosphorylated buffer solution
then treated with protease. Cells were re-seeded at one SCC cluster per T-25 flask and fed using
SCC media. Meiosis commitment media was Stem Pro-34 SFM plus supplements except with
Retinoic acid (Sigma # 951252-250mg) at 100 ng/ml in order to commit to meiosis. Meiotic
committed cells were subcultured on Falcon T-25 flasks. Meiotic committed cells were not
subcultured since cells where quiescent and did not expand. Cell differentiation markers: c-Kit
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(CD117) antibody for meiosis committed cells (Chemicon #CBL1359F), CD9 for Primordial
Germ Cell (Millipore #000010), ES Cell Marker Sample Kit (Millipore #000010), Conjugated
fluorescent antibodies (Upstate/Chemicon #AP124F and AP124R). Cell markers were used
according to company protocols, Catalog No. SCR002. . Normal goat serum was used as a
blocking solution (Chemicon # S26-100ML) at a 4% concentration. Samples were washed with
phosphorylated buffer solution. Cell marker anti-bodies were diluted according to company
protocols.
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CHAPTER 4
ETHYLENE DICHLORIDE INITIATED CHANGES IN THE
PATERNAL IMPRINT IN MOUSE SPERMATOGONIA
The paternal imprint is established in spermatogonial stem (AS) cells or in differentiating
meiosis committed spermatogonia (Aal to A1) prior to meiosis (Holmes, Chang et al. 2006). The
progression of the in vitro tissue culture model of murine AS cells to A1 cells, as discussed in the
last chapter, enables the study of toxicant-induced perturbation of the paternal imprint.
Alkylating and other cytotoxic agents are known to disrupt male reproductive function,
but very little information is available regarding the impact of these toxic agents on epigenetic
patterns or the paternal imprint (Gandini, Sgro et al. 2006). Alkylating and arylating toxicants
were shown to disrupt DNA 5-methylcytosine patterns in cultured mammalian cells (Wilson and
Jones 1983). Benzo (a)pyrene has been shown to alter H3K9 acetylation patterns in MCF7
breast cancer cells (Sadikovic, Andrews et al. 2008). In yeast, nickel chloride blocked histone
acetylation (Ke, Davidson et al. 2006) and Golebiowski et al. (2005) showed the same affects in
mammalian cells.
Histones are major carriers of epigenetic information and either synergistically or
antagonistically provide mechanisms to generate and stabilize genetic imprints. Therefore, the
impact of toxicants such as EDC on histone modification patterns becomes a crucial question in
the establishment of the paternal imprint. Two prominent and opposing histone methylation
markers, H3K4 m3 and H3K9 m3 provide the optimal targets for examination of the effects of
EDC on these histone modification patterns in the paternal imprint. H3K4m3, a strong and stable
activator of transcription, has been hypothesized to serve as a “memory” mark to enforce
transcription in spite of future histone modifications (Ng, Robert et al. 2003; Martin and Zhang
2005; Yu, Zhu et al. 2008). Only a few imprinting control centers are methylated (5methylcytosines) in the male germ line (Delaval, Govin et al. 2007). Following fertilization,
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paternal imprinting control centers have been found to be protected from global demethylation
(5-methylcytosine patterns) by H4K20m3 and H3K9m3, as opposed to the unmethylated allele
which has H3K4me2 and H3 acetylation (Delaval, Govin et al. 2007).
Of all the imprinted DMRs in the mouse genome, only three are known to be methylated
on the paternal allele: RAS guanine release factor 1 (Rasgrf1), Gtl2, and H19 (Delaval, Govin et
al. 2007). These genes are well-studied, and proven protocols are available for methylation
specific PCR techniques. Rasgrf1 has a DMR approximately 30kb upstream of the start site,
which is fully methylated in mature sperm and unmethylated in oocytes (Rayburn, Parker et al.
2004). Immediately 3‟ of this DMR is a 40 copy, 41 nucleotide repeat that is fully methylated in
the male genome.
Gtl2 is part of a complex with Dlk. The Gtl2/Dlk1 locus has three differentially
methylated regions which are methylated only on the paternal locus (Carr, Yevtodiyenko et al.
2007). Only one of the three DMR‟s, 12 kb upstream of Gtl2, is methylated in the male germ
line (Takada, Tevendale et al. 2000). Gtl2 DMR is completely methylated in mature sperm, but
unmethylated in oocytes (Rayburn, Parker et al. 2004). Histone modifications for this locus were
reported to be enriched for H3K9m3 and H4R3m2 in the paternal allele (Verona, Thorvaldsen et
al. 2008).
H19, along with Igf2, was one of the first discovered imprinted genes and is the most
studied (Stoger, Kubicka et al. 1993). The paternal allele is inactive in H19 with the 2 kb
differentially methylated region (DMR) extended over 2 kb at ~ 4kb upstream from the
promoter (Tremblay, Saam et al. 1995). H19 imprinting is present in spermatogonial stem cells
before commitment to meiosis and is completely methylated in spermatogonial stem cells, type
A spermatogonia, and mature sperm. However, H19 is unmethylated in oocytes (Davis, Trasler
et al. 1999; Rayburn, Parker et al. 2004).
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The non-imprinted gene, p16 INK4, was chosen as an additional control DNA region for
these experimental studies. P16 is a cyclin-dependent kinase inhibitor involved in cell cycle
regulation, commonly called a tumor suppressor gene (Little and Wainwright 1995). Studies
suggest that the p16/CDKN2 tumor suppressor gene may be inactivated by methylation of its
promoter, but in healthy organisms CpG, promoter methylation is seldom found in tumor
suppressor genes (Reamon-Buettner and Borlak 2007).
4.1 Treatment of Spermatogonial Stem Cells with EDC
Treating undifferentiated spermatogonial stem cells with EDC and allowing them to
undergo expansion in vitro should model the same DNA and chromatin impacts as in vivo(Sun,
Tao et al. 2008). Once cells have expanded, differentiation to meiotic spermatogonia can be
initiated, and then the DNA 5-methylcytosine and chromatin modification patterns may be
assayed. Controls include both untreated cells and cells treated with 5-aza-2‟-deoxycytidine
(AzadC), a DNA methyltransferase inhibitor. AzadC functions by binding to DNA
Methyltransferase 1 (DNMT1), irreversibly preventing DNA methylation/imprinting
(Dannenberg and Edenberg 2006). Because it was not practical for this dissertation to determine
the rate of incorporation of 5-AzadC in spermatogonial stem cells, the date should not be
included in the final conclusion. Although the data from this variable is very interesting, the
results are not reliable.
Pure spermatogonial stem (As) cell cultures were prepared and grown as described in
Chapter 3. Cultures were maintained with media containing 10 ng/ml GDNF, and 50 ng/ml of
each Bmp4 and Bmp8, but lacking LIF. GDNF appears to stimulate self-renewal of stem cells
and block spermatogonial differentiation (Meng, Lindahl et al. 2000; Kubota, Avarbock et al.
2004). After long term in vitro studies using GDNF (over two years), mouse spermatogonial
stem cells remain genetically and epigenetically stable (Kanatsu-Shinohara, Ogonuki et al.
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2005). This research showed that after culturing for 2 years and a ~ 1085 –fold expansion,
spermatogonial stem cells retained the euploid and androgenetic imprint. Bone morphogenetic
proteins, Bmp 4 and Bmp8b, are reported to be critical for both differentiation of embryo stem
cells to As cells, and the stable maintenance of germ cell self-renewal (Zhao, Liaw et al. 1998;
Lawson, Dunn et al. 1999; Ying, Liu et al. 2000; Baughman and Geijsen 2005). These cultures
were tested for the expression of CD9, and the lack of expression of either Oct-4 or c-kit, as
indicative of As cells (see Figure 3.2, Chapter 3).
It is at the stem cell stage that the genetic and epigenetic heritable information is most
sensitive to external environmental and internal biological damage since damage at the
spermatogonial stem cell stage would produce offspring with systemic mutations. Thus, the
treatments were performed during the As stage by the addition of 5mM EDC, equal to the
concentration in the in vivo experiment in Chapter 2, to the As culture media for 48 hours. For
DNA methylation control, cultures were treated with 5-aza-2-deoxycytidine at 2.5 µM, but for
only 24 hours. After the 24 or 48 hour treatment period, fresh media was added containing 8 nM
RA, but lacking GDNF. Bmp4 and Bmp8 was added to trigger meiosis (Farini, Scaldaferri et al.
2005). The pre-meiotic spermatogonia cells were grown for two weeks prior to harvest. Cells
were harvested by trypsinization, then pelleted and washed with phosphate buffered saline
(PBS).
The addition of RA triggers a meiotic differentiation of As cells (Leid, Kastner et al.
1992; Bowles, Knight et al. 2006). RA induces meiosis-specific genes such as Stra8, Scp3 and
Dmc1; RA also may trigger meiosis through the expression of Stra8 (Koubova, Menke et al.
2006). Although RA may trigger the molecular cascade for meiosis, epigenetic states such as
DNA methylation and histone H3K4 di-methylation patterns, set before RA, can induce meiosis
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(Kaneda, Okano et al. 2004). In vitro fertilization studies have shown that epigenetic
reprogramming is completed before meiosis (Davis and Sharif 2000).
4.2 Check Treatment Groups and Doses
The present experimental work utilized the ChIP assay procedure followed by PCR, to
detect gene specific histone modifications and DNA 5-methylcytosine patterns (Meissner,
Mikkelsen et al. 2008; Meissner, Mikkelsen et al. 2008; Taylor, Wicks et al. 2008; Taylor,
Wicks et al. 2008). In addition to in vitro germ cell cultures, mouse liver harvested from random
male and female mice was obtained from the LSU Veterinary School.
Histone immunoprecipitation antibodies, such as H3K9m3 (abCAM #ab8898) and
H3K4m3 (abCAM #ab8580) are recommended for dilutions of 2 µg per 25 µg of chromatin.
Millipore Chromatin Immunoprecipitation (ChIP) Assay Kit (#17-295) was used according to
the manufacturer‟s protocol for immunoprecipitation and formaldehyde cross-linking. This
assay kit did not include a protease inhibitor. Protease Inhibitor Cocktail (Sigma #P8340) at 1 µl
per 100 µl of sample, according to Sigma protocols, to prevent protease degradation of histones
during DNA purification and immunoprecipitation. Purified chromatin was then sonificated
(Fisher Scientific model FS14) for 3 minutes, which was enough to produce approx 1000 bp
chromatin fragments. This fragment size was estimated by gel electrophoresis analysis.
Following the ChIP procedures, PCR analyses for four specific gene-associated DMRs,
or promoter regions, were performed. Precipitated chromosomes were bisulfite-treated; using
the CPG WIZ® VHL Amplification Kit (Chemicon #S7805) according to the manufacture‟s
protocol and MSPCR was performed on DMR sequences for three genes, Rasgrf1, H19, and
Gtl2 and the promoter region of p16. Disruption of genetic imprinting caused by EDC, either by
hypo- or hypermethylation of DNA, should be detected by these gene-specific selection
methods. Mouse control DNAs, NIH 3T3 and CpG methylated 3T3, were obtained from New
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England BioLabs (Ipswich, MA) for use as standard controls. The histone methylation
modification patterns have been coupled with the DNA 5-methylcytosine patterns in the final
analyses.
MSPCR was performed in 25 µl containing MgCl2 25 mM, 10 mM dNTPs, 2.5 µl 10X
buffer, 1.5 U AccuPrime Taq (Invitrogen # 12339016), 10 pM primers, and 2 µl of sonicated
ChIP isolated DNA. The MSPCR amplification cycles were composed of 1 min at 94ºC, 1 min
at gene specific annealing temperature, and 1 min at 72ºC. Nested PCR was performed with 40
cycles in the first PCR, and 30 cycles in the second round of amplification, obtaining gene
specific primers as custom synthesis from Invitrogen (Carlsbad, CA), with the primer sequences
in Table 4.1.
MSPCR products were digested with BstUI (NEB # R0518L) at 37º C for 12 hours for
Rasgrf1 analyses, resulting in a 284 bp fragment if unmethylated (and uncut) or 50 bp + 160 bp
fragments if methylated. Digestion products were separated by agarose gel electrophoresis in a
5% agarose gel (Amresco #0701) in TBE buffer, for 1 hour at 100V (Figure 3.1).
For Gtl2, H19 and p16 analyses, MSPCR products were digested with Taq1 (Takara Bios
Inc # 1189A) 65º C for 12 hours. The expected Taq1 digestion fragments sizes for Gtl2 were
482 bp (unmethylated) and 145 bp + 337 bp (methylated) (Figure 3.2); for H19 were 422 bp
(unmethylated) and 88 bp + 334 bp (methylated) (Figure 3.3); and for p16 were 492 bp
(unmethylated) and 67 bp + 425 bp (methylated) (Figure 3.4).
4.3 Results of EDC Treatment on Spermatogonial Stem Cells
A total of 20 samples were harvested and tested for both DNA 5-methylcytosine
imprinting status as well as histone modification (H3K4m3 and H3K9m3) status. This was done in
order to determine if ethylene dichloride is able to disrupt or modify genetic imprinting and/or
histone modifications. ChIP assay coupled with methylation specific PCR was used
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Table 4.1 Primer Sequence and Annealing Temperatures

Rasgrf1 DMR

Outside forward 5‟-TAATTTTAAGGTGTAGAATATGGGGTTG-3‟

(52ºC annealing)
Outside reverse 5‟- TAAAAAAACAAAAACAACAATA-3‟
Inside forward 5‟- TAGAGAGTTTATAAAGTTAG-3‟
Inside reverse 5‟-ACTAAAACAAAAATAAAGTTAG-3‟

Gtl2 DMR (52ºC
annealing)

Outside forward 5‟TTAAGGTATTTTTTATTGATAAAATAATGTAGTTT-3‟
Outside reverse 5‟CCTACTCTATAATACCCTATATAATTATACCATAA-3‟
Inside forward 5‟TTAGGAGTTAAGGAAAAGAAAGAAATAGTATAGT-3‟
Inside reverse 5‟TATACACAAAAATATATCTATATAACACCATACAA-3‟

H19 DMR (52ºC

Outside forward 5‟- GAGTATTTAGGAGGTATAAGAATT-3‟

annealing)
Outside reverse 5‟- ATCAAAAACTAACATAAACCCCT-3‟

P16 promoter (65ºC
annealing)

Inside forward

5‟- GTAAGGAGATTATGTTTATTTTTGG-3‟

Inside reverse

5‟- CCTCATTAATCCCATAACTAT-3‟

Outside forward 5‟- GTTGTGTATAGAATTTTAGTAAAG-3‟
Outside reverse 5‟- CCACCCTAACCAATCTATCTACAAC – 3‟
Inside forward

5‟- GTTGTGTATAGAATTTTAGTAAAG-3‟

Inside reverse

5‟- ACCCAAACTACAAAAAAAATACA- 3‟

simultaneously to show gene specific histone modifications and DNA methylation. Results of
this technique showed a definite pattern of EDC induced aberrant DNA methylation and genetic
imprinting patterns. Hypermethylation was expected to be found with H3K9 trimethylation in
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meiotic cells and possibly liver cells. In liver, imprinted genes are expected to keep their
imprint. Paternally imprinted genes retain their preferentially expressed imprint in all tissues
(Cheng, Zhang et al. 2008; Cheng, Zhang et al. 2008). This expression included other mammals,
besides human and mouse. However as shown below, H3K4me3 was found to be coupled
sporadically with hypermethylation in liver. This could possibly be due to random epigenetic
mutations since the liver was obtained from old mice from the LSU Veterinary School.
For the three paternally imprinted genes of interest, 5-methylcytosine patterns were
analyzed from both EDC treated and control spermatogonia. EDC treated meiotic cells were
compared to non-treated meiotic cells, in order to determine whether EDC can disrupt this vital
epigenetic and reproductive process. The results clearly show that EDC has an effect on the
methylation and subsequent imprinting of the three chosen imprinted gene DMRs. However the
effects seem to be limited to H3K4me3 histone modification, while H3K9m3 patterns show no
significant changes. Twenty separate samples from each treatment and gene combination were
tested for DMR methylation and histone modification.
The ChIP and DNA 5-methylcytosine pattern analysis of the DMR region specific for the
Rasgrf1 gene showed perturbation by EDC and 5- AzadC treatment of spermatogonial stem cells
(Figure 4.1). 5- AzadC initiated a loss of methylation, when compared with untreated meiotic
spermatogonia on the H3K9m3 histone modification ChIP isolate, while the lack of results for the
H3K4me3 suggested that no lysine 4 trimethylation was present on the histones of this DMR
region of DNA, for both untreated meiotic patterns and following the 5- AzadC treatment. EDC
treated samples showed hypermethylated DMR’s on both H3K4m3 and H3K9m3 chromatin
isolates, suggesting that the EDC treatment altered the histone modifications to include
trimethylation of lysine 4 on H3. Untreated liver samples displayed the same patterns as
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untreated meiotic spermatogonia, although the 50 bp and 150 bp bands for hypermethylation on
the H3K9m3 ChIP isolate were relatively weak (Figure 3.1).
4.4 Materials and Methods
Purified chromatin was sonificated (Fisher Scientific model FS14) for 3 minutes, which
was enough to produce approx 1000 bp chromatin fragments. This fragment size was estimated
by gel electrophoresis analysis. Histone immunoprecipitation antibodies, H3K9m3 (abCAM
#ab8898) and H3K4m3 (abCAM #ab8580) where used according to company protocols with
dilutions of 2µg per 25µg of chromatin. Millipore Chromatin Immunoprecipitation (ChIP)
Assay Kit (#17-295) was used according to the manufacturer‟s protocol for immunoprecipitation
and formaldehyde cross-linking. This assay kit did not include a protease inhibitor. Protease
Inhibitor Cocktail (Sigma #P8340) at 1µl per 100 µl of sample was adequate to prevent protease
degradation of histones during DNA purification and immunoprecipitation.
After ChIP purification for H3K4m3 and H3K9m3 histone modifications, MSPCR was
performed in order to determine 5-methylcytosine status of Rasgrf1, Gtl2, H19 DMR‟s as well
as promoter of P16. ChIP purified chromatin was bisulphate treated using CPG WIZ® VHL
Amplification Kit (Chemicon #S7805) according to company protocols. MSPCR was performed
using Perkin Elmer Thermocycler (Model No. 2400 ). MSPCR was performed in 25 µl
containing MgCl2 25mM, 10mM dNTPs, 2.5 µl 10X buffer, 1.5U AccuPrime Taq (Invitrogen #
12339016), 10 pM primers, and 2 µl of sonicated ChIP isolated DNA. The MSPCR
amplification cycles were composed of 1 min at 94C, 1 min at gene specific annealing
temperature, and 1 min at 72C. Nested PCR was performed with 40 cycles in the first PCR, and
30 cycles in the second round of amplification. Custom PCFR primers obtained from Invitrogen
(Carlsbad, CA) with sequences and temperatures listed in Table 3.1.
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PCR products were then treated with endonuclease to determine 5-methylcytosine status
of PCR products. For Rasgrf1, PCR products were digested with BstUI (NEB # R0518L) at
37ºC for 12 hours analyses, resulting in a 284 bp fragment if unmethylated (and uncut) or 50 bp
+ 160 bp fragments if methylated (Figure4.1). For Gtl2, H19 and p16 analyses, MSPCR
products were digested with Taq1 (Takara Bios Inc # 1189A) 65ºC for 12 hours. The Taq1
digestion fragments sizes for Gtl2 were 482 bp (unmethylated) and 145 bp + 337 bp
(methylated) (Figure 4.2); for H19 were 422 bp (unmethylated) and 88 bp + 334 bp (methylated)
(Figure 4.3); and for p16 were 492 bp (unmethylated) and 67 bp + 425 bp (methylated) (Figure
4.4). Digestion products were separated by agarose gel electrophoresis in a 5% agarose gel
(Amresco #0701) in TBE buffer, for 1 hour at 100V (Figure 4.1).

Figure 4.1. Rasgrf1, agarose gel electrophoresis of MSPCR analysis of ChIP
preparations. 284 bp is an unmethylated sample. 160bp/50bp is a methylated sample. (K4:
histone H3K4m3; K9, histone H3K9 m3) Treatments include 5- AzadC, EDC, untreated mouse
liver DNA, untreated meiosis-committed spermatogonia and control methylated DNA.
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Table 4.2. Results of the ChIP and MSPCR analyses of 20 samples for the Rasgrf1 with
methylated DMR.
DNA Cytosine

K4

K9

K4

K9

K4

K9

K4

K9

5-AZA

5-AZA

EDC

EDC

Liver

Liver

Meiotic

Meiotic

Hypermethylated

0

7

15

18

3

16

2

18

Unmethyated

13

3

3

0

1

1

5

0

Total

13

11

18

18

4

17

7

18

The results observed in Figure 4.1 remained much the same after the ChIP and MSPCR
analyses of 19 more samples for the DMR associated with the Rasgrf1 gene (Table 4.2).
Apparently 7 out of 20 untreated meiotic spermatogonia samples contained H3K4m3
modifications; these samples were isolatable by the ChIP assay and displayed hypermethylation
(2/7 or 29%) and an unmethylated DNA cytosine pattern (5/7 or 71%). However, none of the 18
H3K9m3 ChIP isolatable, untreated, meiotic spermatogonia samples were found to be
unmethylated (Table 4.2). Liver, somatic tissue provided results very similar to that of untreated
meiotic spermatogonia. The 5- AzadC treatment, which is known to diminish DNA cytosine
methylation, appears to have impacted the histone modification patterns as well, since twice as
many H3K4m3 ChIP isolates were obtained following 5-Aza than for untreated meiotic
spermatogonia. Also, the number of H3K9m3 ChIP isolates was diminished by a third in the 5AzadC treated cells in untreated meiotic spermatogonia. All of the 13 H3K4m3 ChIP isolates were
found unmethylated, while only 3 (27%) of the 11 H3K9m3 ChIP isolates were found to be
unmethylated (Table 4.2). EDC apparently enhanced the trimethylation of lysine 4, as the
number of H3K4m3 ChIP isolates more than doubled (18 versus 7) following EDC treatment,
compared to untreated meiotic spermatogonia. EDC also enhance DNA hypermethylation of the
H3K4me3 modified chromatin, since 83% (15/18) of these ChIP isolates were hypermethylated,
63

compared to only 29% (2/7) for untreated meiotic spermatogonia (Table 4.2). However, EDC
appears to have had no effect on either the DNA cytosine pattern or the H3K9m3 pattern for the
Rasgrf1 DMR.
The second DMR for the imprinted Gtl2 gene provided the same results as those
described above for the Rasgrf1 gene. 5- AzadC initiated a loss of methylation when compared
with untreated meiotic spermatogonia on the H3K9m3 histone modification ChIP isolate, while
the lack of results for the H3K4m3 suggested that no lysine 4 trimethylation was present on the
histones of this DMR region of DNA for both untreated meiotic spermatozoa and the following
5- AzadC treatment (Figure 4.2). EDC treated samples showed hypermethylated DMR‟s on
both H3K4m3 and H3K9m3 chromatin isolates, suggesting that EDC treatment altered the histone
modifications to include trimethylation of lysine 4 on H3. Untreated liver samples displayed the
same patterns as untreated meiotic spermatogonia (Figure 4.2).
The results reported in Figure 4.2 remained much the same after the ChIP and MSPCR
analyses of 19 more samples for the DMR associated with the Gtl2 gene (Table 4.3).
Apparently 6 out of 20 untreated meiotic spermatogonia samples contained H3K4m3
modifications, as they were isolatable by the ChIP assay and displayed hypermethylation (5/6 or
83%) predominantly. However, all 16 of the H3K9m3 ChIP isolates for untreated meiotic
spermatogonia samples were found to be hypermethylated (Table 4.3). The liver provided
results very similar to that of untreated meiotic spermatogonia.
Apparently 5- AzadC treatments had a different impact on the H3K4me3 modification
pattern of the DMR for the Gtl2 gene, as compared to the Rasgrf1 associated DMR (Tables 4.2
and 4.3). Only a third (2/6) as many samples were ChIP isolatable for H3K4m3 modification on
the Gtl2 gene DMR following the 5- AzadC treatment, as compared to untreated meiotic
spermatogonia (Table 4.3). The 5- AzadC treatment initiated a loss of DNA cytosine
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methylation, as both H3K4m3 ChIP isolates were unmethylated and 89% (16/18) H3K9m3 ChIP
isolates were unmethylated, compared with 17% (1/6) and 0% (0/16) unmethylated in H3K4m3
and H3K9m3 ChIP isolates, respectively, for untreated meiotic spermatogonia.

Figure 4.2. Gtl2 MSPCR. Gtl2, agarose gel electrophoresis of MSPCR analysis of ChIP
preparations. 482 bp is an unmethylated sample. 145 bp + 337 bp is a methylated sample. (K4,
histone H3K4m3; K9, histone H3K9 m3) Treatments are 5- AzadC, EDC, untreated mouse liver
DNA, untreated meiosis-committed spermatogonia and control methylated DNA.

Table 4.3. Results of the ChIP and MSPCR Analyses of 20 samples for the Gtl2 DMR
DNA Cytosine

K4

K9

K4

K9

K4

K9

K4

K9

5-AZA

5-AZA

EDC

EDC

Liver

Liver

Meiotic

Meiotic

Hypermethylated

0

2

8

14

2

14

5

16

Unmethylated

2

16

4

0

2

0

1

0

Total

2

18

12

14

4

14

6

16
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EDC apparently enhanced the trimethylation of lysine 4 on Gtl2 DMR, as the number of
H3K4m3 ChIP isolates was doubled (12 versus 6) following EDC treatment, compared to
untreated meiotic spermatogonia (Table 4.3). However, EDC had little effect on the DNA
hypermethylation of the H3K4m3 modified chromatin of the Gtl2 DMR, since 67% (8/12) of
these ChIP isolates were hypermethylated, compared to only 83% (5/6) for untreated meiotic
spermatogonia (Table 3.3). However, EDC appears to have had no effect on either the DNA
cytosine pattern, or the H3K9m3 pattern for the Gtl2 DMR.
The ChIP and DNA 5-methylcytosine pattern analysis of the DMR region specific for the
H19 gene showed perturbation by EDC and the 5- AzadC treatment of spermatogonial stem
cells (Figure 4.3). Untreated meiotic spermatogonia displayed the expected result of the lack of
DNA cytosine methylation on the H3K4m3 ChIP isolate and DNA hypermethylation on the
H3K9m3 ChIP isolate. The 5-AzadC treatment initiated a loss of methylation, when compared
with untreated meiotic spermatogonia on the H3K9m3 ChIP isolate.
The lack of results for the H3K4m3 suggests that no lysine 4 trimethylation was present
on the histones of this DMR region of DNA following the 5- AzadC treatment (Figure 4.3).
Although the 334 bp and 88 bp bands are relatively weak, EDC treated samples showed
hypermethylated DMRs on both of the H3K4m3 and H3K9m3 chromatin isolates, suggesting that
EDC treatment altered the histone modifications to include trimethylation of lysine 4 on H3.
Untreated liver samples displayed the lack of DNA cytosine methylation on both the H3K4m3
and H3K4m3 ChIP isolates, which may suggest the loss of the DNA cytosine methylation
imprint in some somatic tissues (Figure 4.3). However, this was the only sample of 15 H3K9m3
ChIP isolates, found to be unmethylated.
As with the DMRs of Rasgrf1 and Gtl2, the ChIP and MSPCR analyses of 20 samples
for the DMR associated with the H19 gene provided similar results (Table 4.4). Apparently 9
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Figure 4.3. H19 MS/PCR. H19, agarose gel electrophoresis of MSPCR analysis of ChIP
preparations. 422 bp is an unmethylated sample. 88 bp + 334 bp is a methylated sample. (K4,
histone H3K4m3; K9, histone H3K9 m3) Treatments are 5- AzadC, EDC, untreated mouse liver
DNA, untreated meiosis-committed spermatogonia and control methylated DNA.
Table 4.4. Results of the ChIP and MSPCR Analyses of 20 samples for the H19 DMR

DNA Cytosine

K4
5-AZA

K9
5-AZA

K4
EDC

K9
EDC

K4
Liver

K9
Liver

K4
Meiotic

K9
Meiotic

Hypermethylated

1

3

13

16

3

14

4

17

Unmethylated

14

13

2

1

2

1

5

0

Total

15

16

15

17

5

15

9

17

out of 20 untreated meiotic spermatogonia samples contained H3K4m3 modifications, as they
were isolatable by the ChIP assay and displayed hypermethylation (4/9 or 44%) and an
unmethylated DNA cytosine pattern (5/9 or 56%). However, all of the 17 H3K9m3 ChIP
isolatable untreated meiotic spermatogonia samples were found to be methylated (Table 3.4).
Liver samples provided results very similar to that of untreated meiotic spermatogonia. The 567

AzadC treatment, which is known to diminish DNA cytosine methylation, appears to have
impacted the histone modification patterns as well since more H3K4m3 ChIP isolates were
obtained following the 5-AzadC than for untreated meiotic spermatogonia.
All but one (14/15 or 93%) of the 15 H3K4m3 ChIP isolates following 5- AzadC
treatment were found to be unmethylated, while 13 (81%) of the 16 H3K9m3 ChIP isolates were
found to be unmethylated (Table 4.4). EDC apparently enhanced the trimethylation of lysine 4,
since the number of H3K4m3 ChIP isolates was increased (15 versus 9) following EDC
treatment, compared to untreated meiotic spermatogonia. EDC also enhanced DNA
hypermethylation of the H3K4m3 modified chromatin, since 87% (13/15) of these ChIP isolates
were hypermethylated, compared to only 44% (4/9) for untreated meiotic spermatogonia (Table
4.4). However, EDC appears to have had no effect on either the DNA cytosine pattern or the
H3K9m3 pattern for the Rasgrf1 DMR.
In order to understand the effects of EDC treatment on the epigenetic markers and the
paternal imprint, the total number of ChIP isolates for each chromatin modification were
tabulated (Table 4.5), and the percentage of ChIP isolates with DNA hypermethylation found
coupled with each H3K4m3 and H3K9m3 were tabulated (Table 4.6). The EDC treatment of
spermatogonial stem cells not only doubled the number of H3K4m3 ChIP isolates, but also
increased the proportion of those ChIP isolates, hypermethylated by more than 50% compared
to untreated meiotic cells (Tables 4.5 and 4.6).
At the same time, EDC had no apparent effect on either the number of H3K9m3 ChIP
isolates or on the methylation status of H3K9m3 modified chromatin for these three imprinted
DMRs. The 5- AzadC treatment also increased the number of H3K4m3 ChIP isolates, but by
only half as much as EDC, compared to untreated meiotic spermatogonia (Table 4.5). However,
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5- AzadC induced a 50% and a 69% loss of DNA cytosine methylation in H3K4m3 and H3K9m3
ChIP isolates respectively, relative to untreated meiotic spermatogonia (Table 4.6).
Table 4.5 Total ChIP Isolates for each Imprinted Gene DMR Based on Histone Modification.a
Gene DMR

Rasgrf1

Gtl2

H19

5-Aza

5-Aza

EDC

EDC

Liver

Liver

Meiotic

Meiotic

K4

K9

K4

K9

K4

K9

K4

K9

13/20

11/20

18/20

18/20

4/20

17/20

7/20

18/20

(65%)

(55%)

(90%)

(90%)

(20%)

(85%)

(35%)

(90%)

2/20

18/20

12/20

14/20

4/20

14/20

6/20

16/20

(10%)

(90%)

(60%)

(70%)

(20%)

(70%)

(30%)

(80%)

15/20

16/20

15/20

17/20

5/20

15/20

9/20

15/20

(75%)

(80%)

(75%)

(85%)

(25%)

(75%)

(45%)

(75%)

77±8%

37±8% 82±8%

Average 50±35% 75±18% 75±15% 82±10% 22±3%

a

Twenty samples were subjected to the ChIP assay for each gene and histone trimethylation.

Table 4.6 Percent ChIP Isolates Hypermethylated
Gene

5-Aza

5-Aza

EDC

EDC

Liver

Liver

Meiotic

Meiotic

DMR

K4

K9

K4

K9

K4

K9

K4

K9

Rasgrf1

0%

64%

83%

100%

75%

94%

29%

100%

Gtl2

0%

11%

67%

100%

50%

100%

83%

100%

H19

7%

19%

87%

94%

60%

87%

44%

100%

Average 2±4%

31±29% 79±11% 98±3% 62±13% 94±7%
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52±28% 100±0%

An interesting gene specific phenomenon was observed following the 5-Aza treatment
that was not seen following EDC. EDC induced H3K4m3 formation in all three imprinted gene
DMRs, nearly doubling the number of H3K4m3 ChIP isolates for Rasgrf1 and H19 and tripling
the number for Gtl2 (Table 4.5). However, the 5- AzadC treatment provided similar results for
Rasgrf1 and H19, yet decreased the level of H3K4m3 of the Gtl2 DMR by more than 65% (Table
4.5). The reason for this anomaly is not presently known and will require further experimental
work to verify and understand the mechanism(s) involved.
Untreated liver cells displayed similar patterns of DNA 5-methylcytosine and histone
modification to that observed for untreated meiotic spermatogonia. The liver cells had an
expectedly low number of hypermethylated DMRs on H3K4m3 modifications. However, an
unexpected high number of hypermethylated DMRs were found on H3K9m3 (Table 4.6). This
could be due to the fact that samples were collected from older male mice harboring age-acquired
methylation (Mazin 1994). As discussed below, the p16 gene, a non-imprinted control sequence,
showed some minor promoter hypermethylation in liver cells, which suggest that older mice tend
to have naturally occurring age-related aberrant DNA hypermethylation as they age. The p16
gene promoter showed increases in meiotic cell promoter hypermethylation, as would be
expected for condensing chromatin. Male meiotic germ cells are globally hypermethylated, in
order to condense paternal DNA to fit in the sperm head.
For comparisons, a non-imprinted gene region, p16 promoter, was also included in these
analyses. Interestingly, the DNA cytosine methylation patterns were very similar to the imprinted
gene DMRs (Figure 4.4). The ChIP and DNA 5-methylcytosine pattern analysis of the p16
promoter region showed perturbation by EDC and the 5-Aza treatment of spermatogonial stem
cells (Figure 4.4). The 5-AzadC initiated a loss of methylation when compared with untreated
meiotic spermatogonia on the H3K9m3 histone modification ChIP isolate.
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Blank PCR results for the H3K4m3 suggests that no lysine 4 trimethylation was present on
the histones of the p16 promoter region of DNA for both the untreated meiotic and following the
5- AzadC treatment. EDC treated samples showed hypermethylated p16 promoter on both
H3K4m3 and H3K9m3 chromatin isolates, suggesting that EDC treatment altered the histone
modifications to include trimethylation of lysine 4 on H3. Untreated liver samples displayed the
same patterns as untreated meiotic spermatogonia, although the 67 bp and 425 bp bands for
hypermethylation on the H3K9m3 ChIP isolate were relatively weak (Figure 4.4).
A tabulation of 20 samples analyzed for p16 promoter DNA cytosine methylation and
histone modifications yielded the following results. EDC did not significantly alter the H3K4m3
pattern, but may have increased the trimethylation of lysine 9 on H3, since the number of
H3K9m3 ChIP isolated increased by 33% (16 versus 12) (Table 4.7). EDC did, however,
substantially reduce (by 62%) DNA hypermethylation of H3K9m3 ChIP isolates of the p16
promoter sequence (Table 4.7). The 5- AzadC treatment of spermatogonial stem cells initiated a
complete loss of H3K4m3 and a shift to fully (100%) trimethylated on lysine 9 of H3, along with a
complete loss (0%) of DNA cytosine methylation of the p16 promoter region (Table 4.7). These
results clearly indicate that EDC affected both the histone trimethylation and the DNA cytosine
methylation pattern in the promoter sequences of the p16, non-imprinted gene (Table 4.7).
Comparing the p16 promoter ChIP and MSPCR analyses results with those of the
imprinted DMRs, there is a higher level of trimethylation of lysine 4 and decreased trimethylation
on lysine 9 of H3 in the p16 promoter than in the imprinted regions in untreated meiotic
spermatogonia (Tables 4.5 and 4.8). As with the imprinted DMRs, DNA hypermethylation is
also associated with H3K9m3 in the p16 promoter region in untreated meiotic spermatogonia
(Table 4.6 and 4.8). However, unlike the imprinted DMRs, the p16 promoter displays a complete
lack of DNA cytosine methylation in chromatin harboring H3K4m3.
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Figure 4.4. P16, A garose gel electrophoresis of MS/PCR analysis of ChIP preparations. 492 bp
is an unmethylated sample. 67 bp + 425 bp is a methylated sample. (K4, histone H3K4m3; K9,
histone H3K9 m3) Treatments are 5- AzadC, EDC, untreated mouse liver DNA, untreated
meiosis-committed spermatogonia and control methylated DNA.
Table 4.7. Results of the ChIP and MSPCR Analyses of 20 samples for the p16 Promoter
DNA Cytosine

K4

K9

K4

K9

K4

K9

K4

K9

5-AZA

5-AZA

EDC

EDC

Liver

Liver

Meiotic

Meiotic

Hypermethylated

0

0

1

6

1

5

0

12

Unmethylated

0

20

14

10

17

0

16

0

Total

0

20

15

16

18

5

16

12

The 5- AzadC produced a different effect on the histone modification patterns of the
imprinted DMRs than on those of the p16 promoter. The 5-AzadC initiated a dramatic increase in
the trimethylation of lysine 9 and complete removal of trimethylation of lysine 4 on H3 in the p16
promoter. Conversely, no effects were observed on H3K9m3 and an increase in trimethylation of
lysine 4 on H3 was found on DMRs for Rasgrf1 and H19 (but not Gtl2) (Tables 4.5 and 4.8).
Unlike the imprinted DMRs, 5- AzadC also produced a complete loss of DNA cytosine methylation
from the p16 promoter regions harboring H3K9m3 (Tables 4.6 and 4.8).
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EDC also produced a different effect on the DNA cytosine methylation patterns of the p16
promoter, compared to the imprinted DMRs. EDC caused a loss of 62% of the DNA cytosine
methylation on the p16 promoter harboring H3K9m3, compared to no change on the imprinted
DMRs (Table 4.6 and 4.8). EDC may also have increased the formation of H3K9m3 on the p16
promoter, which was not seen in the imprinted DMRs (Tables 4.5 and 4.8).
Table 4.8 Total ChIP Isolates and Percent of Isolates Hypermethylated for P16 Promoter. Based
on Histone Modification.a
P16

5-Aza

5-Aza

EDC

EDC

Liver

Liver

Meiotic

Meiotic

Promoter

K4

K9

K4

K9

K4

K9

K4

K9

Number of ChIP

0/20

20/20

15/20

16/20

18/20

5/20

16/20

12/20

Isolates

(0%)

(100%)

(75%)

(80%)

(90%)

(25%)

(80%)

(60%)

Percent

NA b

0%

7%

38%

6%

100%

0%

100%

Hypermethylated

a

Twenty samples were subjected to the ChIP assay for each gene and histone trimethylation.

b

NA, not applicable as zero ChIP isolates obtained.
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CHAPTER 5
DISCUSSION
It is interesting that the p16 promoter region was found to harbor both H3K4m3 and
H3K9m3 histone modifications in untreated meiotic-committed spermatogonia, since the H3K4m3
is associated with gene expression and the H3K9m3 is associated with genes that are not
expressed and DNA heterochromatin. However, spermatogonial stem cells and early stage
spermatogonia are still diploid, and these results most likely represent the two different
imprinted alleles, one being expressed and the other shut down. The finding that DNA cytosine
hypermethylation associated 100% with H3K9m3, while all of the H3K4m3 chromatin contained
unmethylated DNA for the p16 promoter, supports this conclusion.
Imprinted DMRs would be expected to contain only H3K9m3 and DNA cytosine
hypermethylation on both alleles, unless the paternal imprint has not been fully established in
spermatogonial stem cells or early stage spermatogonia. The untreated spermatogonia DMRs
provided only 82±8% H3K9m3 and 37±8% H3K4m3, suggesting that the imprint is being
processed but is not yet fully established. The fact that these same DMRs were found to be
totally (100%) hypermethylated on H3K9m3 chromatin, but mixed results (52±28) were found
for DNA cytosine methylation on H3K4m3 chromatin, supports this conclusion. However,
exactly when the imprint becomes fully established is not known, except that it must take place
before meiosis and these early stage spermatogonia are only a few cell cycles away from
meiosis.
In meiotic cells, 5-AZA-2'-deoxycytidine was used to determine the effects of a DNA
de-methylating agent on epigenetic pattern establishment. The samples treated with 5-AZA-2'deoxycytidine showed a substantial loss of cytosine methylation from DMRs, regardless of
which lysine residue was trimethylated on both imprinted DMRs and non-imprinted p16
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promoter sequences. Interestingly, 5- AzadC had opposing effects on the level of
trimethylation on imprinted DMRs, than on non-imprinted sequences. 5- AzadC induced an
increase in H3K9m3 on the p16 promoter, and no change on the imprinted DMRs, while a
complete loss of H3K4m3 was found on the p16 promoter in 5-Aza treated spermatogonia.
The most interesting effect of EDC was on genes found on H3K4m3 modification of
imprinted DMRs. The number of samples harboring H3K4m3 in the imprinted DMRs was
doubled by EDC treatment, and the level of cytosine methylation was increased for this
chromatin harboring H3K4m3. This was not the case for the effect of EDC on the nonimprinted p16 promoter region. EDC initiated a substantial loss of cytosine methylation on
chromatin harboring H3K9m3, with little if any effect on the epigenetic patterns of H3K4m3 p16
promoter chromatin.
The differences in the effects of 5-AzadC and EDC on imprinted versus non-imprinted
sequences may reflect the packaging and accessibility of each of these specific DNA regions.
5- AzadC is most likely going to initiate the loss of DNA cytosine methylation throughout
most, if not all of the DNA, while the selective processing of imprinted regions in the presence
of 5- AzadC also results in alterations in the histone modification patterns. Since an even
greater effect of 5-AzadC on the histone modifications was seen in the p16 promoter, it is
possible that this DNA region is in the process of being prepared for dormancy, e.g., H3K9m3
and hypermethylation, during the spermatogonial stem cell stage. The p16 gene is normally
active in stem cells, but is turned off with the vast majority of genes in mature spermatozoa.
EDC had different effects on the level of DNA cytosine methylation on the imprinted DMRs
compared to the p16 promoter, causing a substantial increase in methylation on chromatin
harboring H3K4m3 in imprinted DMRs, as well as a substantial loss of methylation on
chromatin harboring H3K4m3 in the non-imprinted p16 promoter region.
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Neither 5-Aza nor EDC altered the H3K9m3 levels in the imprinted DMRs, while
H3K9m3 levels were decreased by 5-AzadC and increased by EDC in the non-imprinted p16
promoter. This may suggest that the H3K9m3 marks in the imprinted DMRs are protected and/or
no longer accessible in spermatogonial stem cells. This might be the case if these DMRs have
already been imprinted, at least in what constitutes the “histone imprint” component, prior to
reaching the spermatogonial stem cell stage of development. However, both 5- AzadC and EDC
altered the DNA cytosine methylation patterns and the H3K4m3 levels in these DMRs, indicating
that the completion of the imprinting process had not taken place in spermatogonial stem cells.
Other alkylating agents have been shown to initiate global losses of DNA cytosine
methylation (Wilson and Jones 1983; Wilson et al. 1987), and gene specific hypermethylation
following chemical carcinogenesis (Bollati, Baccarelli et al. 2007). EDC appears to be initiating
a loss of DNA cytosine methylation in the non-imprinted promoter, and a gain in the imprinted
DMRs. This effect also appears to be tied to the specific lysine residue that is trimethylated.
H3K4m3 and H3K9m3 are associated with active gene expression and repressed gene expression,
possibly with heterochromatin formation. EDC increased the DNA cytosine methylation of the
H3K4m3 associated chromatin in imprinted regions, while decreasing the DNA cytosine
methylation of the H3K9m3 associated chromatin of the non-imprinted p16 promoter.
Unfortunately, there are a number of additional variables that were not studied in this
experimental study. This first approach to the question of the potential impact of EDC on the
paternal imprint utilized the best known of histone lysine methylation markers, H3K4m3 and
H3K9m3. The transition from di- to tri- methylation of H3K4 and H3K9 lysines is of particular
biological significance. In general, H3K4m3 methylation is linked to transcriptionally active
chromatin or euchromatin (Lachner and Jenuwein 2002), while H3K9m3 methylation is linked to
repressed transcription or heterochromatin (Lachner and Jenuwein 2002). However, H3K9m2
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methylation recently has also been discovered in euchromatin (Vakoc, Mandat et al. 2005; Vakoc,
Sachdeva et al. 2006). Mono- and di-methylated lysines at H3K4 and H3K9 may prove to be play
important roles in the paternal imprint, as well. Additionally, there are a number of other histone
modifications, such as mono-, di- and trimethylation of lysines H3K27, H3K36, H3K79, and
H4K20, arginine methylation at H4R3, and acetylation of H2B11, H3K9, H3K14, etc. The best
approach most likely would entail the comparison of H3K4m3 and H3K9m3 patterns in mature
spermatozoa first, followed by the determination of the specifics regarding the temporal processing
and establishment of the paternal imprint using the in vitro spermatogonial stem cell model.
In summary, the present data suggest that EDC can disrupt 5-methylcytosine patterns and/or
histone modification patterns on imprinting DMRs in the developing paternal gamete. The
mechanism could involve EDC affecting CpG binding proteins, histone binding proteins,
methyltransferases, or the formation of DNA base pair mutations, which may cause aberrations in
5-methylcytosine and/or histone modification patterns. DNA and epigenetic repair or maintenance
mechanisms could be targeted by EDC. Further experimental work will be required to both verify
the present results and clarify the histone modification patterns in the imprinted DMRs.
Elucidation of the enzymatic mechanisms involved in the processing and establishment of the
paternal imprint will also be important to understanding how genotoxic agents affect gamete
specific imprints.
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CHAPTER 6
CONCLUSIONS
The purpose of this research was to study the effects of EDC on mammalian
reproductive functions, especially involving epigenetic imprinting patterns including histone
modifications. This study further delineates adverse health risks to humans exposed to this high
use toxicant in today‟s chemical industry. As described in Chapter 2, EDC was clearly a
testicular toxicant in male mice. Treatment of male mice with EDC at doses equal to or above 5
mg/kg daily for five days resulted in a dose-dependent testicular toxicity, with a precipitous loss
of spermatogonia and progressing to a Sertoli cell-only state in many seminiferous tubules.
Treatment of male mice to 10 mg/kg daily for five days rendered these mice permanently sterile,
while male mice treated with 5 mg/kg dose displayed a short, sterile period of 3 to 5 weeks (two
of three mice) and permanent sterility (one of three mice). A published testicular pathology
scoring protocol for human testes was adapted for mice, and then used to clearly demonstrate a
decreasing testicular score with an increasing dose of EDC. Thus, the in vivo study of male
mice demonstrated that EDC interferes with the maintenance and development of spermatogonia
and subsequent spermatogenesis (Daigle et al. 2009). This work provides the first evidence in
the scientific literature that EDC is a testicular toxicant and potentially, a reproductive risk to
humans.
The next question to be addressed in this research work was the impact of EDC on
epigenetic patterns that form the paternal imprint. However, the paternal imprint is established
in spermatogonial stem cells and/or during the early stages of the meiosis-committed
spermatogonia prior to meiosis. This research requires the isolation of these developing gametes
at specific cell stages in order to study the EDC exposure impact of epigenetic patterns specific
to the paternal imprint. Also, alterations in epigenetic patterns may easily be masked by
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contaminating somatic cells or by germ cells at different stages of development, therefore
having different gene-specific DNA cytosine methylation and histone modification patterns. In
addition, heritable deleterious changes in the paternal imprint in few spermatogonia may easily
be undetectable in a million cells without some form of controlled cellular expansion.
Therefore, an in vitro tissue culture model of the appropriate stages of spermatogenesis was
required to advance this project.
As described in Chapter 3, an in vitro model of mouse spermatogonial stem cell cultures
was developed. Using a set of three cellular antigen markers (Oct 4, CD 9, c-Kit) that provided
distinct patterns for mouse embryonic stem cells, spermatogonial stem cells, and meiosiscommitted spermatogonia, pure cultures of spermatogonial stem cells were prepared from
embryonic stem cells. These spermatogonial stem cell cultures were stable and maintained as
self-renewing stem cells for several months, prior to initiating differentiation and turning these
stem cells into meiosis-committed spermatogonia. Previous reports required the use of feeder
layers to maintain cultures of spermatogonial stem cells in a stable, self-renewing growth state.
By capitalizing on recent advances in stem cell growth factors, the present work
developed protocols for isolating and maintaining spermatogonial stem cells on plastic without
the need for feeder cells. This was important, since the presence of somatic feeder cells would
interfere with the germ cell analyses of epigenetic imprint patterns. Pure cultures of
spermatogonial stem cells could now be maintained, treated with EDC or other toxicants, and
subsequently triggered to begin the early stages of spermatogenesis. Thus, a model for studying
the establishment, as well as toxicant induced interference in the establishment, of the
mammalian paternal imprint was now available.
In the interest of studying the effects of EDC on the paternal imprint, spermatogonial
stem cell cultures were treated with EDC. These cultures were subsequently expanded,
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following the initiation of meiosis-committed differentiation prior to harvest and analyses of
gene-specific DNA cytosine methylation and histone trimethylation (H3K4m3 and H3K9m3)
patterns. Four genes were chosen for these analyses; three were the known paternal gamete
imprinted genes (Rasgrf1, Gtl2, and H19), and the fourth was a prominent, non-imprinted gene,
p16. The results of these experiments clearly demonstrated that EDC could interfere with the
establishment of spermatogonial epigenetic patterns and the paternal imprint. Histone
trimethylation patterns have not been previously reported for these imprinted genes, and the data
from the present study suggests a few
While the 5- AzadC treated samples initiated the anticipated loss in DNA cytosine
methylation in the majority of sequences studied, the results are inconclusive. 5-AzadC was
included as a positive demethylating control, but cultured spermatogonial stem cells were not
synchronized for optimal DNA synthesis effects and the actual level of DNA incorporation of 5AzadC in propagating spermatogonial stem cells was not determined. Since there are no studies
to establish treatment protocols for in vitro spermatogonial stem cells and that timing and dosage
are critical in order to block establishment of genetic imprinting information, more research
needs to be done to determine uniform and optimal standards.
The accepted theory is that histone H3K4m3 modifications are found on active chromatin,
while an H3K9m3 modification, along with hypermethylation (5-methylcytosine), is found on
repressed chromatin. Imprinting of these gene specific DMRs entails the formation of H3K9m3
and DNA cytosine hypermethylation. The present research results further support this
conclusion. The majority of the imprinted DMR alleles were found to harbor H3K9m3 coupled
with DNA cytosine hypermethylation in meiosis-committed spermatogonia, while the promoter
for the non-imprinted p16 gene was found to contain predominantly H3K4m3, coupled with
DNA cytosine hypomethylation, in these same cells. Both EDC and 5- AzadC disrupted the
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establishment of the imprint in treated spermatogonial stem cells. The DMRs for the imprinted
genes in spermatogonia were found to harbor hypomethylated DNA (cytosine residues), coupled
with histone H3K9m3, as well as increased proportion of H3K4m3 chromatin. EDC initiated
inappropriate hypermethylation of many of these sequences, including DMR chromatin
harboring H3K4me3 in treated spermatogonia. The present work also found agent induced
mismatches between the H3K9me3 DNA cytosine hypomethylation patterns in these imprinted
genes in meiosis-committed spermatogonia. The ramifications of mismatched lysine
trimethylation modifications with DNA cytosine methylation patterns in the paternal imprint are
unknown. The consequences of passing on these aberrant, epigenetic, paternal imprint patterns
to a newly formed zygote can only be speculated to be deleterious to the development and
survival of the embryo, but this is only speculation, based on the accepted dogma.
The paternal imprint pattern has been reported to be established in spermatogonial stem
cells. The present work suggests that the process of establishing the imprint DMRs associated with
Rasgrf1, Gtl2, and H19 is not complete until meiosis-committed spermatogonia prepare for meiosis,
after the spermatogonial stem cell stage. Spermatogonia are premeiotic and therefore diploid, so
that one allele may be repressed, while the second allele could be open and expressed. However, as
the paternal imprint is established, both alleles should become repressed and condensed as
heterochromatin, prior to meiosis, that is, the histone H3 lysine 9 residues become trimethylated,
and the DNA cytosine residues become hypermethylated. Imprinting of the DMRs should entail the
complete trimethylation of H3K9, loss of the H3K4m3, and DNA cytosine hypermethylation of both
alleles.

This was not the case in harvested, untreated, early- stage meiosis-committed

spermatogonia, as approximately 30% of samples displayed the presence of H3K4m3. Since
approximately 50% of these DMR alleles harboring H3K4m3 were also found to be
hypermethylated, it is probable that these alleles are in the midst of being imprinted and removal of
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H3K4m3 follows DNA cytosine hypermethylation. It is not presently known whether histone
modifications guide DNA cytosine methylation, or vice versa.
The implications for the change of DNA cytosine hypermethylation on DMRs chromatin
harboring H3K4m3 histone modification are enormous. The EDC induced alteration in the H3K4m3
pattern, observed in this study, suggests significant perturbation of gene expression, which may
disrupt the imprint program for embryonic development. For example, the interaction between
Inhibitor of Growth 4 (ING4), which is a histone acetyltransferase (HAT) complex and a tumor
suppressor protein, and H3K4m3 augments HBO1 acetylation activity on H3 tails and drives H3
acetylation at ING4 target promoters. ING4 facilitates apoptosis in response to genotoxic stress and
inhibits anchorage-independent cell growth, and these functions depend on ING4 interactions with
H3K4m3 (Hung, Binda et al. 2009). Although this complex was not shown to be associated with
Rasgrf1, Gtl2, or H19, this could be a possible mechanism for EDC‟s impact on epigenetic patterns.
To correctly express a gene with this altered H3-K4m3 pattern, the zygote would have to
make a decision as to which epigenetic modification is correct. The conceptus would either change
imprint, the DNA 5-methylcytosine pattern, to match the histone modification or change the histone
modification to match the original imprint pattern. Should the epigenetic repair mechanism choose
to express both copies, the developing conceptus would experience gene dosage problems (da
Rocha, Charalambous et al. 2009). In studies of Dlk1/Pref1, when both copies harbored paternal
imprint (repressed) or both copies harbored the maternal imprint (active), the phenotype showed
growth abnormalities as well as developmental defects in muscle, cartilage/bone and placenta
(Georgiades, Watkins et al. 2000; Takada, Tevendale et al. 2000; Georgiades, Watkins et al. 2001;
Tevendale, Watkins et al. 2006). If the cell decides to repress both copies, this would be the same as
a null gene. In Prader-Willi Syndrome (PWS), the maternally inherited copies of these genes are
silent, leaving the paternal copies of the genes to be expressed. PWS results from the loss of paternal
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copies of this region. If a newly formed zygote chooses to repress both alleles the phenotype may
resemble PWS. However, unlike uniparental dysomy in which the conceptus has either both
maternal or paternal imprints, this conceptus would just have a null at that locus in effect, a loss of
expressible locus. Since no data exist concerning aberrant imprinted histone modifications, more
research will be needed to determine if this epigenetic mutation has heritable consequences.
In conclusion, this research has shown that EDC targets mouse testes and spermatogenesis in
vivo, which may have reproductive, embryonic, and genetic inheritance ramifications. EDC has
been shown to alter H3K4m3 patterns on Rasgrf1, Gtl2 and H19 paternal imprinted gene DMRs.
These disruptions most likely will have a serious, major impact on a newly formed zygote, causing
embryonic death, systemic genetic disease, and/or significant birth defects.
6.1 Future Direction
The present work on the perturbation of the epigenetic patterns of the mammalian paternal
imprint is not definitive. Although EDC initiated substantial changes in the histone trimethylation
and DNA cytosine patterns, too many questions regarding unknowns in the epigenetic imprint
patterns of the paternal (and maternal) gamete remain unanswered. Additional controls and
experimental studies will be required to clarify these issues.
The final imprint histone modification patterns must be delineated in mature spermatozoa.
Although doubtful, H3K4m3 and H3K9m3 could be found to play a minor role in the paternal imprint,
while mono- or di-methylated lysine residues or even a different histone modification is
predominantly in the mechanics of the paternal imprint. However, elucidation of the mechanisms
involved in both the establishment and the functions of these epigenetic imprint patterns will require
the characterization of spermatogonial stem cells, early stage meiosis-committed spermatogonia,
and mature spermatozoa for mono-, di-, and trimethylation of H3K4 and H3K9 sites, as well as
methylation, acetylation, and phosphorylation of additional histone sites. In fact, should EDC have
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an effect on methyltransferase, then other transferases should or could be affected. Other
modifications to histones, which seem to be linked to histone methylation, such as acetylation,
should also be included in any future research. The paucity of published literature regarding these
histone modification patterns in imprinted sites provides an open opportunity to advance this
research.
The timing of the process of establishing the paternal imprint also needs further elucidation.
Future experiments in this area will require finer controls and further validation of the stages of the
spermatogonia, especially the early stage meiosis-committed spermatogonia. The cellular antigen
markers chosen (Oct 4, CD 9, and c-Kit) were the consensus markers for each stage of cell
differentiation, but additional markers might improve the resolution in the step-wise differentiation
of these germ cells. Spermatogonial Stem Cell markers such as α6- and β1-integrins should also be
included in future studies (Shinohara, Avarbock et al. 1999). Two monoclonal antibodies,
designated BC7 and CA12, were found to identify mouse testicular germ cells during early meiotic
prophase (Koshimizu, Watanabe et al. 1993). These findings should be included in future research
as well. Surface and intercellular markers for negative controls would add to the confidence of
these in vitro tissue culture results.
Future research would include more samplings along the time-line of treated and non-treated
cells. Our results included a snapshot of DNA cytosine methylation and histone modifications.
Samples taken daily (every 24 hours) after differentiation and/or chemical treatments may show not
only the results of treatment, but also transitions and repair mechanisms of DNA 5-methylcytosine
and histone modifications. Data on both treated and non-treated cells would clarify the relationships
and linkages of DNA 5-methylcytosine and histone modifications patterns. Obviously, this approach
would also establish what the normal epigenetic patterns for these germ cells.
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While DMRs are thought to regulate DNA 5-methylcytosine patterns in promoter regions the
actual effect of EDC treatments on gene-specific promoter regions might be worthy of investigation.
The results from P16 showed that EDC lowered the DNA cytosine methylation level in chromatin
harboring H3K9m3, but the impact on the promoter regions of Rasgrf1, Gtl2, and H19 remain
unknown. The effects of EDC may well be limited to the DMRs or Imprinting Control Regions.
Since these regions control promoter methylation, a disruption of promoter regions may be directed
from DMRs or Imprinting Control Regions.
Of course, the most definitive research would include in vivo experiments on mice.
Unfortunately, the ability to isolate sufficient cell numbers of approximately 100% purity at each
stage and time-line from spermatogonial stem cells to spermatogonia A to meiosis from live mice
would be difficult at the present time. This leaves the in vitro approach as established and delineated
in the present research work. However, as details of epigenetic patterns are reported in the
literature, the present in vitro model approach should add substantially to the literature and advance
the scientific knowledge base regarding the details of the epigenetic patterns laid down in the
paternal imprint, as well as the impact of toxicants such as EDC on these patterns.
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